Advertisement

Grundlagen II pp 270-377 | Cite as

Immunbiologische Aspekte des zentralen und peripheren Nervensystems

  • G. Uhlenbruck
Part of the Handbuch der Neurochirurgie book series (NEUROCHIRURGIE, volume 1 / 2)

Zusammenfassung

Es ist für den Neurochirurgen, Neurologen und denjenigen, der sich physiologisch-chemisch mit dem Zentralnervensystem befaßt, wichtig zu wissen, daß Gehirn und Nervensystem Schauplatz von Immunreaktionen sein können. Es sind vor allem drei Dinge von Interesse:
  1. a)

    Das Feststellen von normalen und pathologischen Bestandteilen des Nervensystems.

     
  2. b)

    Es muß mit der Möglichkeit gerechnet werden, daß durch Bestandteile des Gehirns Immunreaktionen ausgelöst werden können.

     
  3. c)

    Das Gehirn nimmt, immunbiologisch gesehen, eine Sonderstellung ein.

     
  4. d)

    Immunbiologische Reaktionen erlauben nicht nur festzustellen, was vorhanden ist, sondern sie erlauben auch, den Weg und die Wirkungsweise einzelner Stoffe zu verfolgen, z. B. von Toxinen und Hormonen.

     

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adams, E. V.: Response of cultured chicken brain neuroglial cells to infection with Rous sarcoma virus. J. Nat. Cancer Inst. 37, 347 (1966).PubMedGoogle Scholar
  2. Adams, R. D.: A comparison of the morphology of the human demyelinative diseases and experimental “allergic” encephalomyelitis. In: “Allergic” encephalomyelitis. Springfield, Ill., USA: Ch. C. Thomas 1959.Google Scholar
  3. Ahlström, C. G.: Einige aktuelle Probleme aus dem Gebiet der Virus-Tumor-Forschung. Dtsch. med. Wschr. 88, 801 (1963).PubMedGoogle Scholar
  4. Ala, A. F., and D. J. C. Shearman: A case of autoimmune haemolytic anaemia, thrombocytopenia and Landry-Guillain-Barré syndrome. Acta haemat. (Basel) 34, 361 (1965).Google Scholar
  5. Allan, T. M.: Blood groups and age groups. Lancet 267, 292–293 (1954).Google Scholar
  6. Allen, N., and E. Reagan: Glucuronidase activities in cerebrospinal fluid. Arch. Neurol. (Chic.) 11, 144 (1964).Google Scholar
  7. Allerand, C. D., and M. D. Yahr: Gamma-globulin affinity for normal human tissue of the central nervous system. Rep. Sci. 144, 1141 (1964).Google Scholar
  8. Alvord, E. C.: Discussion of the interrelationship of demyelinating diseases. Summary and concluding remarks. In: “Allergic” encephalomyelitis. Springfield, Ill., USA: Ch. C. Thomas 1959.Google Scholar
  9. Alvord, E. C.: The relationship of hypersensitivity to infection, inflammation and immunity. J. Neuropath. exp. Neurol. 25, 1 (1966).Google Scholar
  10. Amemori, T., and R. Altsohul: Tissue changes after injections of Freund’s adjuvans. Zbl. allg. Path. path. Anat. 104, 352 (1963).Google Scholar
  11. Amos, D. B., M. Ztmpft, and P. Armstrong: H-5.A and H-6.A, two mouse isoantigens on red cells and tissues detected serologically. Rep. Transplant. 1, No 3 (1963).Google Scholar
  12. Anderson, J. R.: Auto-antibodies in diseases of man. Brit. med. Bull. 19, 251 (1963).PubMedGoogle Scholar
  13. Andre, J., R. Schwartz, J. Mrtus, and W. Dameshek: Lymphoid responses to skin homografts. I. Studies in normal rabbits. Blood 19, 313 (1962a).PubMedGoogle Scholar
  14. Andre, J., R. Schwartz, J. Mrtus, and W. Dameshek: Lymphoid responses to skin homografts. II. Effects of antimetabolites. Blood 19, 334 (1962b).PubMedGoogle Scholar
  15. Anthony, H. M., and M. Parsons: Globulin on cells of cancer patients. Nature (Lond.) 206, 275 (1965).Google Scholar
  16. Atanasiu, P., P. Lepine and P. Dragonas: Etude cinetique du virus rabique en culture de tissue à l’aide des anticorps fluorescents et des coupes ultra-fines. Ann. Inst. Pasteur 105, 813 (1963).Google Scholar
  17. Atanasiu, P., G. Orth, J. Sisman and C. Barreau: Identification immunologique du virion rabique en cultures cellulaires par les anticorps specifiques conjugi.es it la ferritine. C. R. Acad. Sci. (Paris) 257/15, 2204 (1963).Google Scholar
  18. Autilio, L. A., W. T. Norton, and R. D. Terry: The preparation and some properties of purified myelin from the central nervous system. J. Neurochem. 11, 17 (1964).PubMedGoogle Scholar
  19. Ayres, W. W.: Formation of myelin forms in brain. U.S. Armed Forces med. J. 9, 17 (1958).Google Scholar
  20. Baker, R. W. R., R. H. S. Thompson, and K. J. Zilkha: Serum fatty acids in multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 27, 408 (1964).PubMedGoogle Scholar
  21. Ball, E. J., and E. A. Caspary: Immun-conglutinin level in guinea pigs with experimental “allergic” encephalomyelitis. Life Sci. 10, 737 (1963).PubMedGoogle Scholar
  22. Bammer, H.: Nachweis des β10- Globulins als normaler Bestandteil des Liquors durch Immunelektrophorese. Klin. Wschr. 41, 1084 (1963).PubMedGoogle Scholar
  23. Bammer, H.: Immunelektrophoretische Darstellung eines thermolabilen und Hydrazin-empfindlichen β1-Globulins im menschlichen Serum und Liquor. (Eine Komplementkomponente?) J. Neurol. Sci. 1, 129 (1964).Google Scholar
  24. Bardin, C. W., R A Liebelt, and A. G. Liebelt: Effect of hypophysial isografts on the mammary glands of intact and hypophysectomized mice. Endocrinology 74, 586 (1964).PubMedGoogle Scholar
  25. Baron, S., and C. E. Bucklar: Protective effect of antibody or elevated temperature on intracerebral infection of mice with encephalomyocarditis virus. J. Immunol. 93, 45 (1964).PubMedGoogle Scholar
  26. Barron, K. D., J. Bernson, and A. R. Hess: Abnormalities in brain esterases in multiple sclerosis. Proc. Soc. exp. Biol. (N.Y.) 113, 521 (1963).Google Scholar
  27. Barry, G. T.: Colominic acid, a polymer of N-acetylneuraminic acid. J. exp. Med. 107, 507 (1958).PubMedGoogle Scholar
  28. Bauer, E.: Tumorzellen im Liquor cerebrospinalis. Z. Laryng. Rhinol. 43, 191 (1964).Google Scholar
  29. Bauer, H., & D. Habeck: Fortschritte in der Liquorforschung. Internist (Berl.) 4, 535 (1963).Google Scholar
  30. Bauer, H., D. Matzelt & Sceiwarze, I.: Untersuchungen über Hirnproteine bei Einwirkung von Lysolecithin auf Hirnhomogenate. Klin. Wschr. 40, 251 (1962).PubMedGoogle Scholar
  31. Beauregard, M., P. Boulanger, and W. A. Webster: The use of fluorescent antibody staining in the diagnosis of rabies. Canad. J. comp. Med. 29, 141 (1965).PubMedGoogle Scholar
  32. Benda, R.: Passive immunoprophylaxis and immunotherapy of inhalation lymphocytic choriomeningitis in guinea-pigs. J. Hyg. Epidem. (Praha) 8, 243 (1964).Google Scholar
  33. Benda, R., and J. Cinatl: Active immunoprophylaxis of experimental inhalation lymphocytic choriomeningitis. J. Hyg. Epidem. (Praha) 8, 252 (1964).Google Scholar
  34. Berg, O., and S. J. Dencker: Studies on sera of animals with experimental allergic encephalomyelitis and patients with multiple sclerosis using immune precipitation in agar gel and immuno-electrophoresis. Sep. Acta path. microbiol. scand. 54, Fasc. 4 (1962).Google Scholar
  35. Berg, O., and B. Källn: Studies of experimental allergic encephalomyelitis and multiple sclerosis with aid of glia cell culture. Acta neurol. scand. 41, Suppl. 13, 625 (1965).Google Scholar
  36. Berg, O., and B. Källn: An in vitro gliotoxic effect of serum from patients with multiple sclerosis and some other neurologic conditions. Kgl. Fysiogr. Sällsk. Lund Förh. 31, 87 (1962).Google Scholar
  37. Bernheimer, A. W., and W. E. van Heyningen: The relation between the tetanus toxin-fixing and influenca virus inhibiting properties of ganglioside. J. gen. Microbiol. 24, 121 (1961).Google Scholar
  38. Berson, S. A., R. S. Yalow, S. M. Glicx, and J. Roth: Immunoassay of protein and peptide hormones. Metabolism 13, 1135 (1964).PubMedGoogle Scholar
  39. Beutner, E. H., A. Djanian, and E. Witebsky: Serological studies in rabbit antibodies to the rabbit anterior pituitary. Immunology 7, 172 (1964).PubMedGoogle Scholar
  40. Beutner, E. H., E. J. Holborow, and G. D. Johnson: A new fluorescent antibody method: mixed antiglobulin immunofluorescence or labelled antigen indirect immunofluorescence staining. Nature (Lond.) 208, No 5008 (1965a).Google Scholar
  41. Beutner, E. H., I. L. Leff, G. Fazekas, and E. Witebsky: Immunologic studies of two cases of fatal myasthenia gravis. J. Amer. med. Ass. 191, 489 (1965b).Google Scholar
  42. Beutner, E. H., E. Witebsky, E. Rose, and J. R. Gerbasi: Localization of thyroid and spinal cord autoantibodies by fluorescent antibody technique. Proc. Soc. exp. Biol. (N.Y.) 97, 712 (1958).Google Scholar
  43. Biegeleisen, J. Z., M. S. Mitchell, B. B. Marcus, D. L. Rhoden, and R. W. Blumberg: Immunofluorescence techniques for demonstrating bacterial pathogens associated with cerebrospinal meningitis. Part I and II. J. Lab. clin. Med. 65, 976, 990 (1965).Google Scholar
  44. Billingham, R. E.: Transplantation immunity and the maternal-fetal relation. New Engl. J. Med. 270, 667 (1964).PubMedGoogle Scholar
  45. Black, P. H., W. P. Rowe, H. C. Turner, and R. J. Huebner: A specific complement-fixing antigen present in SV 40 tumor and transformed cells. Proc. nat. Acad. Sci. (Wash.) 50, 1148 (1963).Google Scholar
  46. Böhme, D., W. Kersten, G. Paal, and H. Kersten: Instability of myelin antigens derived from human brain. Lancet 1964 II, 886–888.Google Scholar
  47. Böhme, D., J. M. Lee, H. A. Schneider, and M. Wachstein: The response of the reticuloendothelial system of inbred resistant and susceptible mice in the pathogenesis of allergic encephalomyelitis. J. Neuropath. exp. Neurol. 25, 311 (1966).PubMedGoogle Scholar
  48. Böhme, D., G. Paal, W. Kersten, and H. Kersten: Skin reactions in neurologie patients after intracutaneous administration of proteolipid extracted from human brain. Nature (Lund.) 197, 609 (1963).Google Scholar
  49. Bogoch, S., K. T. Dussik, C. Fender, and P. Conran: Longitudinal clinical and neurochemical studies on schizophrenic and manic-depressive psychoses. Amer. J. Psychiat. 117, 409 (1960).Google Scholar
  50. Bogoch, S., G. Paal, W. Kersten, and H. Kersten: Skin reactions in neurologic patients after intracutaneous administration of proteolipid extracted from human brain. Nature (Lond.) 197, 609 (1963).Google Scholar
  51. Bollag, W.: Suppression of the immunological reaction by methylhydrazines, a new class of antitumour agents. Experientia (Basel) 19, 304 (1963).Google Scholar
  52. Bonin, O., U. F. Unterharnscheidt: Zur Neurovirulenzprüfung von Poliomyelitis-Lebendimpfstoffen. I. Grundlagen, Technik and Bewertung des Versuchs zur Messung der Neurovirulenz für den Affen. Arch. Psychiat. Nervenkr. 206, 260 (1964).Google Scholar
  53. Brönnestam, R., S. J. Dencker, and B. Swahn: Fibrinogen in cerebrospinal fluid. Arch. Neurol. (Chic.) 4, 288 (1961).Google Scholar
  54. Bornstein, M. B.: A tissue culture approach to demyelinative disorder. Nat. Cancer Inst. Monogr. No 11, 197 (1963).Google Scholar
  55. Bornstein, M. B., and S. H. Appel: The application of tissue culture to the study of experimental “allergic” encephalomyelitis. J. Neuropath. exp. Neurol. 20, 141 (1961).Google Scholar
  56. Bornstein, M. B., and S. M. Crain: Functional studies of cultured brain tissues as related to “demyelinative disorders”. Science 148, 1242 (1965).PubMedGoogle Scholar
  57. Boyden, S. V.: The adsorption of proteins on erythrocytes treated with tannic acid and subsequent hem-agglutination by antiprotein sera. J. exp. Med. 93, 107 (1951).PubMedGoogle Scholar
  58. Bradley, R. M., and J. N. Kanfer: The action of galactose oxidase on several sphingoglycolipids. Biochim. biophys. Acta (Amst) 84, 210 (1964).Google Scholar
  59. Brady, R. O.: Immunochemical properties of glycolipids. Amer. Oil Chem. Soc. 43, 67 (1966).Google Scholar
  60. Brandt, R., H. Guth & R. Müller: Zur Frage der Organspezifität von Lipoidantikörpern. Klin. Wschr. 1926, 655.Google Scholar
  61. Brauman, J., H. Brauman, and J. L. Pasteels: Immunoassay of growth hormone in cultures of human hypophysis by the method of complement fixation: comparison of the growth hormone secretion and the prolactin activity. Nature (Lond.) 202, No 4937, 1116 (1964).Google Scholar
  62. Brent, L.: Tissue transplantation. Progr. Allergy 5, 271 (1958).Google Scholar
  63. Brody, M. J.: Electrical activity in sympathetic nerves of immunologically sympathectomized rats. Proc. Soc. exp. Biol. (N.Y.) 114, 565 (1963).Google Scholar
  64. Brühl, P., U. Bucn, U. Steinmetz & E. Weber: Fehlender immunologischer Nachweis von menschlichem Wachstumshormon im Liquor cerebrospinalis. Klin. Wschr. 42, 1033 (1964).Google Scholar
  65. Brunngraber, E. G., and B. D. Brown: Preparation of sialomucopolysaccharides from brain mitochondrial fractions. Biochim. biophys. Acta (Amst.) 69, 581 (1963).Google Scholar
  66. Brunngraber, E. G., and B. D. Brown: Heterogeneity of sialomucopolysaccharides prepared from whole rat brain. Biochim. biophys. Acta (Amst) 83, 357 (1964).Google Scholar
  67. Bubenik, J., and P. Koldovsky: The mechanism of antitumour immunity studied by means of transfer of immunity. Folia biol. (Praha) 10, 427 (1964).Google Scholar
  68. Buckell, M., and M. C. Robertson: Enzyme studies in cerebral tumours. Lactate dehydrogenase, glucose phosphate isomerosa, acid and alcaline phosphatase in plasma, ventricular cerebrospinal fluid and tumour cyst fluid from cases of glioma and cerebral secondary carcinoma. Brit. J. Cancer 19, 83 (1965).PubMedGoogle Scholar
  69. Burnet, F. M.: Autoimmune disease. The Keith Inglis Lecture for 1961, Science 133, 307 (1961).PubMedGoogle Scholar
  70. Burnet, F. M.: Theories of immunity. In: Conceptual advances in immunology and oncology. Hoeber Medical Division. New York: Harper & Row, Publ. 1962.Google Scholar
  71. Burnet, F. M.: Immunological factors in the process of carcinogenesis. Brit. med. Bull. 20, 154 (1964).PubMedGoogle Scholar
  72. Burnet, F. M.: Antikörper and Immunität. Med. Prisma 1, 1 (1965).Google Scholar
  73. Buscn, H.: Biochemistry of the cancer cell. New York: Academic Press 1962.Google Scholar
  74. Carnegie, P. R., and C. E. Lumsden: Encephalitogenic peptides from spinal cord. Nature (Lond.) 209, 1354 (1966).Google Scholar
  75. Caspary, E. A.: Comparison of immunological specifity of gamma globulins in the cerebrospinal fluid in normal and multiple sclerosis subjects. J. Neurol. Neurosurg. Psychiat. 28, 61 (1965).PubMedGoogle Scholar
  76. Caspary, E. A.: Precipitating antibody in multiple sclerosis and experimental allergic encephalomyelitis. Specific binding of radio-iodinated encephalitogenic factor. J. Neurol. Neurosurg. Psychiat. 29, 103 (1966).Google Scholar
  77. Caspary, E. A., and E. J. Ball: Effect of treatment with 2-mercaptoethanol on tanned red cell agglutinating antibodies in allergic encephalomyelitis. Nature (Lond.) 207, 1305 (1965).Google Scholar
  78. Caspary, E. A., and E. J. Field: Antibody response to central and peripheral nerve antigens in rat and guinea-pig. J. Neurol. Neurosurg. Psychiat. 28, 179 (1965).PubMedGoogle Scholar
  79. Caspary, E. A., E. J. Field, I. Macleod, and C. Smith: Circulating antibody to saline brain extracts in multiple sclerosis. Z. Immun - Forsch. 125, 459 (1963).Google Scholar
  80. Caspary, E. A., R. E. Sinden, and E. J. Field: Some observations on the role of circulating antibody in protection against experimental allergic encephalomyelitis. Z. Immun.-Forsch. 130, 454 (1966).Google Scholar
  81. Chase, M. W.: A critique of attempts at passive transfer of sensitivity to nervous tissue. In: “Allergic” encephalomyelitis. Springfield, Ill., USA: Ch. C. Thomas 1959.Google Scholar
  82. Chirigos, M. A., L. B. Thomas, R. S. Humphreys, J. P. Glynn, and A. Goldin: Therapeutic and immunological response of mice with meningeal leukemia (L 1210) to challenge with an antifolic-resistant variant. Cancer Res. 24, 409 (1964).PubMedGoogle Scholar
  83. Christensen Lou, H. O., J. Clausen, and F. Bierring: Phospholipids and glycolipids of tumours in the central nervous system. J. Neurochem. 12, 619 (1965).Google Scholar
  84. Clarke, D. W., and L. Geiger: Effects of experimental allergic encephalomyelitis serum of fatty acid output of brain slices. Nature (Loud.) 201, 401 (1964).Google Scholar
  85. Clarke, J. K., D. S. Dane, and G. W. A. Dick: Viral antibody in the cerebrospinal fluid and serum of multiple sclerosis patients. Brain 88, 953 (1965).PubMedGoogle Scholar
  86. Clausen, J.: Immunoelectrophoresis — a survey of its application in clinical chemistry. Sci. Tools 10, No 3 (1963).Google Scholar
  87. Clausen, J., S. J. Dencker, and L. Svennerholm: Proposed standardization of analysis of cerebrospinal fluid proteins. Acta neurol. stand., Suppl. 10, 40, 89 (1964).Google Scholar
  88. Cohen, S. M., I. A. Triandaphilli, J. L. Barlow, and J. Hotohin: Immunofluorescent detection of antibody to lymphocytic choriomeningitis virus in man. J. Immunol. 96, 777 (1966).PubMedGoogle Scholar
  89. Condie, R. M., R. Monson, and R. A. Good: Prevention of experimental allergic encephalomyelitis. Fed. Proc. 18, 563 (1959).Google Scholar
  90. Condie, R. M., & P. Latzer: Die tierischen Gifte in der Chemie. Biochem. Z. 197, 222 (1928).Google Scholar
  91. Coox, R. J.: Reversed passive haemagglutination systems for the estimation of tetanus toxins and antitoxins. Immunology 8, No 1 (1965).Google Scholar
  92. Coombs, R. E. A., A. M. Cowles, and G. D. Ingram: The serology of conglutination and its relation to disease. Oxford: Blackwell scientific publications 1962.Google Scholar
  93. Coons, A. H., and M. H. Kaplan: Localization of antigen in tissue cells. II. Improvements in a method for the detection of antigen by means of fluorescent antibody. J. exp. Med. 91, 1 (1950).PubMedGoogle Scholar
  94. Cragg, B. G., and P. K. Thomas: Changes in nerve conduction in experimental allergic neuritis. J. Neurol. Neurosurg. Psychiat. 27, 106 (1964).PubMedGoogle Scholar
  95. Crowle, A. J.: Delayed hypersensitivity and its allergic implications. Ann. Allergy 22, 215–228 (1964).PubMedGoogle Scholar
  96. Cruickshank, B., and A. R. Currie: Localization of tissue antigens with the fluorescent antibody technique: Application to human anterior pituitary hormones. Immunology 1, No 13 (1958).Google Scholar
  97. Cumings, J. N.: The chemistry of myelin and some aspects of myelination. Some biochemical considerations regarding different forms of demyelination. In: Mechanisms of demyelination, edit. by A. S. Rose and C. M. Pearson, p. 44, 58. New York: McGraw-Hill Book Co. 1963.Google Scholar
  98. Cumings, J. N.: Some lipid diseases of the brain section of neurology. Proc. roy. Soc. Med. 58, 21, (1965).PubMedGoogle Scholar
  99. Cumings, J. N., R. C. Shortman, and T. Skrbic: Lipid studies in the blood and brain in multiple sclerosis and motor neurone disease. J. clin. Path. 18, 641 (1965).PubMedGoogle Scholar
  100. Cunningham, V. R., J. G. Rimer, and E. J. Field: Serum protein profile in experimental “allergic”encephalomyelitis of the guinea pig. Exp. Neurol. 8, 371 (1963).Google Scholar
  101. Cuzner, M. L., A. N. Davison, and N. A. Gregson: The chemical composition of vertebrate myelin and microsomes. J. Neurochem. 12, 469 (1965).PubMedGoogle Scholar
  102. Dameshek, W.: Theories of autoimmunity. In: Conceptual advances in immunology and oncology. New York: Hoeber Medical Division, Harper & Row, Publ. 1962.Google Scholar
  103. Danon, D., C. Howe, and L. T. Lee: Interaction of polylysine with soluble components of human erythrocyte membranes. Biochim. biophys. Acta (Amst) 101, 201 (1965).Google Scholar
  104. David, J. R., and P. Y. Paterson: In vitro demonstration of cellular sensitivity in allergic encephalomyelitis. J. exp. Med. 122, 1161 (1966).Google Scholar
  105. Davidson, J. D.: Studies on the mechanism of action of 6-mercaptopurine in sensitive and resistant L 1210 leucemia in vitro. Cancer Res. 20, 225 (1960).PubMedGoogle Scholar
  106. Day, E. D.: The immunochemistry of cancer. Springfield (Ill.): Ch. C. Thomas 1965.Google Scholar
  107. Day, E. D., S. Lassiter, B. S. Mahaley, and M. S. Mahaley: The localization of radioantibodies in human brain tumors. III. Radioiodination of pre-purified localizing antibody. J. Nuclear Med. 6, 38 (1965).Google Scholar
  108. Day, E. D., S. Lassiter, B. Woodhall, J. L. Mahaley, and M. S. Mahaley: The localization of radioantibodies in human brain tumors. I. Preliminary exploration. Cancer Res. 25, 859 (1965).Google Scholar
  109. Dencker, S. J.: Sex and age as differentiating factors in some cerebrospinal fluid variables. Kgl. Fysiogr. Sällsk. Lund, Förh. 30, No 11 (1960).Google Scholar
  110. Dencker, S. J.: Variation of total cerebrospinal fluid proteins and cells with sex and age. World Neurology 3, 778 (1962).PubMedGoogle Scholar
  111. Dencker, S. J.: Studies on specific cerebrospinal 8-globulin components. Acta neurol. scand., Suppl. 4, 39, 317 (1963).Google Scholar
  112. Dencker, S. J.: Immuno-electrophoretic investigation of cerebrospinal fluid 6-globulins in multiple sclerosis. Acta neurol. stand. Suppl. 10, 40, 57 (1964).Google Scholar
  113. Dencker, S. J., R. Brönnestam, and B. Swahn: Demonstration of large blood proteins in cerebrospinal fluid. Neurology (Minneap.) 11, No 5 (1961).Google Scholar
  114. Dencker, S. J., and B. Swahn: Clinical value of protein analysis in cerebrospinal fluid. Lunds Univ. Arch., N.F., Avd. 2, 57, No 10 (1961).Google Scholar
  115. Dencker, S. J., and B. Swahn: Proteins of central nervous origin present in cerebrospinal fluid. Nature (Lond.) 194, No 4825 (1962).Google Scholar
  116. Dencker, S. J., B. Swahn and B. Ursing: Protein pattern of cerebrospinal fluid during the course of acute polyradiculoneuropathy. Acta med. scand. 175, 499 (1964).PubMedGoogle Scholar
  117. Dencker, S. J., E. Svennilson, and B. Swahn: Protein pattern of cerebrospinal fluid in tumour of the central nervous system. Swedish Cancer Soc. Yearbook 3, 222 (1962).Google Scholar
  118. Depieds, R., G. Cartouzou, S. Lissitzky & H. Gignoux: Sur les caractères immunochimiques des extraits de tissu cérébral de lapin. Rev. franç. Etud. clin. biol. 8, 653 (1963).PubMedGoogle Scholar
  119. Dingman, W., and B. Sporn: Molecular theories of memory. Science 144, No 3614, 26 (1964).PubMedGoogle Scholar
  120. Dodd, M. C., N. J. Bigley, G. A. Johnson, and R. H. Mccluer: Chemical aspects of inhibitors of Rho(D) antibody. Nature (Lond.) 204, 549 (1964).Google Scholar
  121. Doery, H. M., and E. A. North: The interaction of staphylococcal toxin and ganglioside. 1. Inactivation of the lethal effect of staphylococcal toxin in mice. Aust. J. exp. Biol. med. Sci. 39, 333 (1961).PubMedGoogle Scholar
  122. Druckrey, H., S. Ivankovic & R. Preussmann: Selektive Erzeugung maligner Tumoren im Gehirn and Rückenmark von Ratten durch N-Methyl-N-nitrosoharnstoff. Z. Krebsforsch. 66, 389 (1965).Google Scholar
  123. Dumanov, I.: The relation between the nervous system and the infection of immunity. VII. Effect of the different functional states of the cerebral cortex on immunogenesis in swine. Nauki Bulgar. 6, 5 (1962).Google Scholar
  124. Duran-Reynolds, M. L.: Viruses, nucleic acids and cancer, p. 574. Baltimore: Williams & Wilkins 1963.Google Scholar
  125. East, J., D. M. V. Parrott, and J. Seamier: The ability of mice thymectomized at birth to survive infection with lymphocytic choriomeningitis virus. Virology 22, 160 (1964).Google Scholar
  126. Edgar, G. W. F., and A. H. Tingey: “Sulphatides” and “neutral cerebrosides” in demyelination. Psych. Neurol. Neurochir. 66, 543 (1963).Google Scholar
  127. Ehrlich P.: Gesammelte Werke. Berlin-Heidelberg-New York: Springer 1960.Google Scholar
  128. Eisen, A. H., G. Kápráti, T. Lnszl, F. Adermann, J. P. Robb, and H. L. Bacal: Immunologic deficiency in ataxia telangiectasia. New Engl. J. Med. 272, 18 (1965).PubMedGoogle Scholar
  129. Ejima, T.: A mucopolysaccharide from human cerebral cortex. Tohoku J. exp. Med. 61, 2 (1955).Google Scholar
  130. Emmart, E. W., R. W. Bates, and W. A. Turner: Localization of prolactin in rat pituitary and in a transplantable mammotropic pituitary tumor using fluorescent antibody. J. Histochem. Cytochem. 13, 182 (1965).PubMedGoogle Scholar
  131. Faillace, L. A., and S. Bogoch: Quantitative separation of human brain glycolipoids: isolation of an aminoglycolipoid. Biochem. J. 82, 527 (1962).PubMedGoogle Scholar
  132. Falke, D.: Virusbedingte Tumoren. Dtsch. med. Wschr. 90, 440 (1965).PubMedGoogle Scholar
  133. Faurbye, A., L. Lundberg, and K. A. Jensen: Studies on the antigen demonstrated by Malis in serum from schizophrenic patients. Acta path. microbiol. scand. 61, 633 (1964).PubMedGoogle Scholar
  134. Fedinec, A. A., and H. A. Matzke: The relationship of toxin and antitoxin injection site to tetanus development in rat. J. exp. Med. 110, 1023 (1959).PubMedGoogle Scholar
  135. Feigen, G. A., N. S. Peterson, W. W. Hofman, G. H. Genter, and W. E. van Heyningen: The effect of impure tetanus toxin on the frequency of miniature end-plate potentials. J. gen. Microbiol. 33, 489 (1963).PubMedGoogle Scholar
  136. Ferguson, K. A.: Starch-gel electrophoresis-application to the classification of pituitary proteins and polypeptides. Metabolism 13, No 10 (1964).Google Scholar
  137. Fessel, W. J.: Autoimmunity and mental illness: preliminary report. Nature (Lond.) 193, 1005 (1962).Google Scholar
  138. Fessel, W. J., H. D. Kurland, and R. P. Cutler: Serological distinction between functional psychoses. Rep. Arch. int. Med. 113, 669 (1964).Google Scholar
  139. Field, E. J., and E. A. Caspary: Behaviour of blood-platelets in multiple sclerosis. Lancet 1964a I, 876.Google Scholar
  140. Field, E. J., and E. A. Caspary: Protective effect of encephalitogenic factor in experimental allergic encephalomyelitis. Nature (Lond.) 201, 936 (1964b).Google Scholar
  141. Field, E. J., and D. Hughes: Toxicity of motor neurone disease serum for myelin in tissue culture. Brit. med. J. 2, 1399 (1965).PubMedGoogle Scholar
  142. Field, E. J., A. Ridley, and E. A. Caspary: Specificity of human brain and nerve antibody as shown by immunofluorescence microscopy. Brit. J. exp. Path. 44, 631 (1963).PubMedGoogle Scholar
  143. Filipp, G.: Die Rolle des Nervensystems in allergisch-anaphylaktischen Vorgängen. I, II und III. Acta allergol. 21, 201 (1966).PubMedGoogle Scholar
  144. Finger, H.: Arbeiten aus dem Paul-Ehrlich-Institut, dem Georg-Speyer-Haus und dem Ferdinand-BlumInstitut zu Frankfurt a. M. Herausgegeben von Prof. Dr. G. Heymanns, Frankfurt a. M. Heft 60: Das Freundsche Adjuvans. Stuttgart: Gustav Fischer 1964.Google Scholar
  145. Fisch, G.: Über die Aktivität von Caeruloplasmin bei neurologischen und psychiatrischen Erkrankungen, im besonderen bei multipler Sklerose. Confin. neurol. (Basel) 24, 257 (1964).Google Scholar
  146. Fischer, K., & E. Dorszewski: Ein Beitrag zur Immunfluorescenztechnik zum Nachweis cellulär fixierter Antikörper. Mschr. Kinderheilk. 113, 175 (1965).PubMedGoogle Scholar
  147. Fitschen, W.: A quantitative study of antigen-antibody combination during disk electrophoresis in acrylamide gel using iodine-131 labelled human growth hormone. Immunology 7, 307 (1964).PubMedGoogle Scholar
  148. Fjerdingstad, E. J., Th. Nissen, and H. H. Roigaard-Petersen: Effect of ribonucleic acid (RNA) extracted from the brain of trained animals on learning in rats. Scand. J. Psychol. 6, 1 (1965).Google Scholar
  149. Folch-Pt, J.: Discussion of techniques for quantitation of encephalitogenic activity in experimental animals. Distribution and properties of proteolipid fractions. Discussion of the activity of encephalitogenic materials in different species. In: “Allergic” encephalomyelitis. Springfield (Ill.): Ch. C. Thomas Publ. 1959.Google Scholar
  150. Folch-Pt, J.: Chemical pathology of the nervous system. London: Pergamon Press 1961.Google Scholar
  151. Folch-Pt, J., and H. Bauer: Brain lipids and lipoproteins, and the leucodystrophies. Amsterdam: Elsevier Publ. Co. (1963).Google Scholar
  152. Folch-Pt, J., and M. B. Lees: Distribution and properties of proteolipid fractions. In: “Allergic” encephalomyelitis, p. 253. Springfield (Ill.): Ch. C. Thomas 1959.Google Scholar
  153. Folch-Pt, J.: Some considerations on the structure of proteolipids. Fed. Proc. 23, part 1, 630 (1964).Google Scholar
  154. Forrester, J. A., D. C. Dumonde, and E. J. Ambrose: The effects of antibodies on cells Immunology 8, 37 (1965).Google Scholar
  155. Freund, J., and M. M. Lipton: Experimental allergic encephalomyelitis after the excision of the injection site of antigen-adjuvant emulsion. J. Immunol. 75, 454 (1955).PubMedGoogle Scholar
  156. Frick, E.: Immunelektrophoretische Untersuchungen über „spezifische“ Proteine im Liquor cerebrospinalis. Klin Wschr. 43, 357 (1965).PubMedGoogle Scholar
  157. Frick, E., & L. Scheid-Seydel: Untersuchungen mit J131-markiertem 8-Globulin zur Frage der Abstammung der Liquoreiweißkörper. Klin. Wschr. 36, 857 (1958).PubMedGoogle Scholar
  158. Friede, R. L., and M. Knollen: Quantitative enzyme profiles of plaques of multiple sclerosis. Experientia (Basel) 20, 130 (1964).Google Scholar
  159. Friedenreich, V.: The Thomsen hemagglutination phenomenon. Kopenhagen: Levin & Munksgaard 1930.Google Scholar
  160. Friedenreich, V., and Th. Andersen: On the existence, outside human blood, of substances convertible into receptors T. Acta path. microbiol. scand. 4, 236 (1929).Google Scholar
  161. Friedman, H. P., and B. S. Wenger: Identification of two distinct rabbit antibodies directed against different antigenic components of avian brain. Immunology 9, 467 (1965a).PubMedGoogle Scholar
  162. Friedman, H. P., and B. S. Wenger: Adult brain antigens demonstrated in chick embryos by fractionated antisera. J. Embryol. exp. Morph. 13, 35 (1965b).PubMedGoogle Scholar
  163. Gaidamovic, S., & D. S. Muou: Quelques propriétés des hémagglutinines du virus de l’encéphalite japonaise B. Bull. Org. mond. Santé 30, 173 (1964).Google Scholar
  164. Gaisford, W., and A. C. P. Campbell: British Empire Cancer Campaign. 36th Annual report, part 2a, p. 533, 1958.Google Scholar
  165. Gammack, D. B., and R. I. Hector: A study of serum proteins in acute schizophrenia. Clin. Sci. 28, 469 (1965).PubMedGoogle Scholar
  166. Garcia, J. H., H. Okazaki, and A. S. Aronson: Blood-frequencies and astrocytomata. J. Neurosurg. 20, 397 (1963).PubMedGoogle Scholar
  167. Geerling, H., H. J. Angel, G. Löffler & K. F. Weinges: Uber die radio-immunologische Bestimmung von Proteohormonen. Dtsch. med. Wschr. 90, 825 (1965).PubMedGoogle Scholar
  168. Georgi, F., G. G. Honegger, H. P. Rieder & R. Withricr: Beeinflussung der experimentellen allergischen Encephalomyelitis durch ein Cytostatikum der Methylhydrazinreihe. Rely. physiol. pharmacol. Acta 21, 381 (1963).Google Scholar
  169. Gibb, B., & K. Arnold: Untersuchungen zum Nachweis blutgruppengeprägter Antigene in lyophilisierter Dura mater. Zbl. Neurochir. 26, 136 (1965).Google Scholar
  170. Gilland, O., and I. Petersen: The effect of ACTH on EMG in multiple sclerosis patients. Acta neurol. scand. 41, 120 (1965).PubMedGoogle Scholar
  171. Gilliland, P. F., and T. E. Prout: Immunologic studies of octapeptides. I. Radioionisation of oxytocin. II. Production and detection of antibodies to oxytocin. Metabolism 14, 912, 918 (1965).PubMedGoogle Scholar
  172. Gipsen, R., G. J. P. Schmittmann, and B. Saathof: Rabies vaccine derived from suckling rabbit brain. Arch. ges. Virusforsch. 15, 366 (1965).Google Scholar
  173. Girard, A., A. S. Greig, and D. Mitchell: Encephalomyelitis of swine caused by a haemagglutinating virus. Res. Vet. Sci. 5, 294 (1964).Google Scholar
  174. Girard, J., M. Y. van Caillie & M. Vest: Ursachen der unspezifischen Hämagglutinationshemmung in der immunologischen Wachstumshormonbestimmung und Möglichkeiten ihrer Verhütung. Schweiz. med. Wschr. 94, 332 (1964).PubMedGoogle Scholar
  175. Gjessing, L. R.: Studies of functional neural tumors. I. Urinary 3-methoxy-4-hydroxy-phenyl-metabolites. Scand. J. clin. Lab. Invest. 15, 463 (1963a).PubMedGoogle Scholar
  176. Gjessing, L. R.: Studies of functional neural tumors. II. Cystathioninuria. Scand. J. clin. Lab. Invest. 15, 474 (1963b).PubMedGoogle Scholar
  177. Gjessing, L. R.: Studies of functional neural tumors. III. Cystathionine in the tumor tissue. Scand. J. clin. Lab. Invest. 15, 479 (1963c).Google Scholar
  178. Gjessing, L. R.: Studies of functional neural tumors. IV. Isolation and identification of urinary cystathionine. Scand. J. clin. Lab. Invest. 15, 601 (1963d).Google Scholar
  179. Gjessing, L. R.: Studies of functional neural tumors. V. Urinary excretion of 3-methoxy-4-hydroxyphenyl-lactic acid. Scand. J. clin. Lab. Invest. 15, 649 (1963e).Google Scholar
  180. Gold, P., and S. O. Freedman: Demonstration of tumor-specific antigen in human colonic carcinomata by immunological tolerance and absorption techniques. J. exp. Med. 121, 439 (1965).PubMedGoogle Scholar
  181. Goldschmidt, E.: The genetics of migrant and isolate populations. Baltimore: Williams & Wilkins 1962.Google Scholar
  182. Good, R. A.: Immunologic competence: its cellular basis, clinical and experimental deficiencies, ontogeny and phylogeny. In: Mechanisms of demyelination, p. 119–145. New York: McGraw-Hill Book Co. 1963a.Google Scholar
  183. Good, R. A.: Experimental allergic encephalomyelitis: A model for study of pathology, pathogenesis, prevention and treatment of autoimmune diseases. In: Mechanism of demyelination (edit. A. S. Rose and C. M. Pearson). New York: McGraw-Hill Book Co. 1963b.Google Scholar
  184. Gorshunova, L. P., M. I. Parasonis, and M. Sn. Promyslov: Mucolipids of the brain in the process of formation of post-vaccinal antirabic immunity. Nature (Lond.) 210, 1279 (1966).Google Scholar
  185. Goss, D. A., and J. Lewis: Immunologic differentiation of luteinizing hormone and human chorionic gonadotropin in compounds of high purity. Endocrinology 74, 83 (1964).PubMedGoogle Scholar
  186. Grabar, P., and P. Burtin: Immunoelectrophoretic analysis. New York: Elsevier Publ. 1964.Google Scholar
  187. Grace, J. T.: Clinical aspects of immunity in untreated cancer. Ann. N.Y. Acad. Sci. 114, Art. 2, 736 (1964).Google Scholar
  188. Grace, J. T., D. M. Perese, R. S. Metzgar, T. Sababe, and B. Holdridge: Tumor autograft responses in patients with glioblastoma multiforme. J. Neurosurg. 18, 159 (1961).Google Scholar
  189. Granzer, E., G. F. Fuhrman & G. Ruhenstroth-Baver: Untersuchungen über die mit Neuraminidase abspaltbaren Neuraminsäurederivate aus Oberflächenmembranen normaler Leberzellen und Asciteshepatomzellen von Ratten. Hoppe-Seylers Z. physiol. Chem. 337, 52 (1964).PubMedGoogle Scholar
  190. Gray, G. M.: The isolation and partial characterization of the glycolipids of BP8/C3H ascites-sarcoma cells. Biochem. J. 94, 91 (1965).PubMedGoogle Scholar
  191. Greene, H. S. N.: Transplantation of tumors to brains of heterologous species. Cancer Res. 11, 529 (1951).PubMedGoogle Scholar
  192. Greene, H. S. N.: Transplantation of human brain tumors to brains of laboratory animals. Cancer Res. 13, 422 (1953).PubMedGoogle Scholar
  193. Greene, H. S. N.: Heterotransplantation of tumors. Ann. N.Y. Acad. Sci. 69, 525 (1957a).Google Scholar
  194. Greene, H. S. N.: Heterotransplantation of tumors. Ann. N.Y. Acad. Sci. 69, 818 (1957b).PubMedGoogle Scholar
  195. Greene, H. S. N., and E. K. Harvey: Metastasis of heterologously transplanted tumors. Cancer Res. 24, No 10, 1678 (1964).PubMedGoogle Scholar
  196. Grossman, M., W. Sussman, D. Gottfried, C. Quock, and W. Ticknor: Immunofluorescent techniques in bacterial meningitis. Amer. J. Dis. Childr. 107, 356 (1964).Google Scholar
  197. Haas, G. H., and L. L. M. van Deenen: Chemical structure and serological activity of synthetic and natural cardiolipin. Nature (Lond.) 206, No 4987, 935 (1965).Google Scholar
  198. Haas, R., & R. Thomssen: Immunologische Adjuvantien. Dtsch. med. Wschr. 86, 1482 (1961).Google Scholar
  199. Haas, V. H., G. M. Briggs, and S. E. Steward: Inapparent lymphocytic choriomeningitis infection in folic acid deficient mice. Science 126, 405 (1957a).PubMedGoogle Scholar
  200. Haas, V. H., G. M. Briggs, and S. E. Steward: Folic acid deficiency and the sparing of mice infected with the virus of lymphocytic choriomeningitis. Virology 3, 15 (1957b).PubMedGoogle Scholar
  201. Hadley, H. G.: Cybernetics, microorganisms and neoplastic disease. Oncologia (Basel) 17, 221 (1964).Google Scholar
  202. Hakomori, S. I., and R. W. Jeanloz: Isolation of a glycolipid containing fucose, galactose, glucose, and glucosamine from human cancerous tissue. J. biol. Chem. 239, 360 (1964).Google Scholar
  203. Hallauer, C.: Die Virusätiologie der Tumoren. Berner Rektoratsreden, Bern 1961.Google Scholar
  204. Hamburger, R. N., and S. E. Mills: Passive immune kill of cells in tissue culture Immunology 8, 454 (1965).Google Scholar
  205. Handa, SH., and T. Yamakawa: Chemistry of lipids of posthemolytic residue or stroma of erythrocytes. XII. Chemical structure and chromatographic behaviour of hematcsides obtained from equine and dog erythrocytes. Jap. J. exp. Med. 34, 293 (1964).PubMedGoogle Scholar
  206. Handsciiuitmacher, R. E., and A. D. Welch: Agents which influence nucleic acid metabolism. In: The nucleic acids (E. Chargaff and J. N. Davidson, eds.), vol. III, p. 453. New York: Academic Press 1960.Google Scholar
  207. Hardegree, M. C.: Separation of neurotoxin and hemolysin of Clostridium tetani. Proc. Soc. exp. Biol. (N.Y.) 119, 405 (1965).Google Scholar
  208. Harris, G. W.: Entwicklung und heutiger Stand der Neuroendocrinologie. Dtsch. med. Wschr. 90, 61 (1965).Google Scholar
  209. Hartog, M., M. A. Gaafar, B. Meisser, and T. R. Fraser: Immunoassay of serum growth hormone in acromegalic patients. Brit. med. J. 1964 p. 1229.Google Scholar
  210. Hashem, N., and M. L. Barr: Mitogenic effect of rabies vaccine on cultures of lymphocytes in diseases of the nervous system. Lancet 1963 I, 1029.Google Scholar
  211. Hashem, N., and D. H. Carr: Mitogenic stimulation of peripheral lymphocyte cultures by autologous lymphocyte extracts in autoimmune diseases. Lancet 1963 I, 1030.Google Scholar
  212. Hass, W. K.: Soluble tissue antigens in human brain tumor and cerebrospinal fluid. Arch. Neurol. 14, 443 (1966).PubMedGoogle Scholar
  213. Heard, D. H., G. V. F. Seaman, and I. Simon-Reuss: Electrophoretic mobility of cultured mesodermal tissue cells. Nature (Lond.) 190, No 4780, 1009 (1961).Google Scholar
  214. Rechter, O., and I. D. K. Kalkerston: On the nature of macromolecular coding in neuronal memory. Perspect. Biol. Med. 7, 183 (1964).Google Scholar
  215. Heitmann, R., & G. Uhlenbruck: Über den Nachweis „liquorspezifischer“ Proteinkomponenten. Dtsch. Z. Nervenheilk. 188, 187 (1966).Google Scholar
  216. Hellström, K. E., and G. Möller: Immunological and immunogenetic aspects of tumor transplantation. Progr. Allergy 9, 158 (1965).Google Scholar
  217. Henle, W., L. A. Chambers, and V. J. Groupé: The serological specificity of particulate components derived from varous normal mammalian organs. J. exp. Med. 74, 495 (1941).Google Scholar
  218. Henson, R. A., G. M. Stern, and V. C. Thompson: Thymectomy for myasthenia gravis. Brain 88, 11–28 (1965).PubMedGoogle Scholar
  219. Herrlich, P., & C. E. Sekeris: Identifizierung von N-Acetyl-noradrenalin im Urin eines Patienten mit Neuroblastom. Hoppe-Seylers Z. physiol. Chem. 339, 249–250 (1964).Google Scholar
  220. Heyningen, W. E. van: Tentative identification of the tetanus toxin receptor in nervous tissue. J. gen. Microbiol. 20, 310 (1959).Google Scholar
  221. Heyningen, W. E. van: The fixation of tetanus toxin by ganglioside. J. gen. Microbiol. 24, 107 (1961).Google Scholar
  222. Heyningen, W. E. van: The fixation of tetanus toxin, strychnine, serotonin and other substances by ganglioside. J. gen. Microbiol. 31, 375 (1963).Google Scholar
  223. Heyningen, W. E. van: The fixation of tetanus toxin by ganglioside. J. gen. Microbiol. 31, 437 (1963).Google Scholar
  224. Heyningen, W. E. van: The fixation of tetanus toxin by ganglioside. Biochem. Pharmacol. 12, 437 (1963).Google Scholar
  225. Heyningen, W. E. van, and S. N. Arseculeratne: Exotoxins. Ann. Rev. Microbiol. 18, 195 (1964).Google Scholar
  226. Heyningen, W. E. van, and P. A. Miller: The fixation of tetanus toxin by ganglioside. J. gen. Microbiol. 24, 107 (1961).Google Scholar
  227. Heyningen, W. E. van, and R. J. Woodman: The fixation of tetanus by frog brain. J. gen. Microbiol. 31, 389 (1963).Google Scholar
  228. Hitzig, W. H.: Immunbiologische Reaktionen des cellulären und des humoralen Systems. Schweiz. med. Wschr. 93, 1433 (1963).Google Scholar
  229. Hochwald, G. M., and G. J. Thorbecke: Occurrence of myeloma-like y-globulin in C.S.F. of a four-month old infant with hydrocephalus. Pediatrics 33, No 3 (1964).Google Scholar
  230. Hoeber Medical Division: Conceptual advances in immunology and oncology. New York: Harper & Row, Publ. Inc. 1963.Google Scholar
  231. Hoelzl-Wallach, D. F., and E. H. Eylar: Sialic acid in the cellular membrane of Ehrlich ascites-carcinoma cells. Biochim. biophys. Acta (Amst) 52, 594 (1961).Google Scholar
  232. Hollan, S. R., E. Novak, S. Kòszeghy, and E. Stark: Immunochemical study of denerved muscle proteins. Life Sci. 4, 1779 (1965).PubMedGoogle Scholar
  233. Holmberg, B.: The isolation and composition of a cytotoxic polypeptide from tumor fluids. Z. Krebsforsch. 66, 65 (1964).Google Scholar
  234. Holst, E.: Studies on antilipoidal immune globulin. 1. Influence of normal components of human serum and cerebrospinal fluid on the outcome of the complement fixation test with cardiolipin antigen, and variation in this influence following heat inactivation. Acta path. microbiol. scand. 62, 356–366 (1964).PubMedGoogle Scholar
  235. Holst, E.: Studies on antilipoidal immune globulin. 2. Reactivity in lepromatous leprosy with a lecithin-free cardiolipin antigen (Cardchol) after ordinary and prolonged heat inactivation. Acta path. microbiol. scand. 62, 367 (1964).PubMedGoogle Scholar
  236. Hooghwinkel, G. J. M., P. F. Borri, and G. W. Bruvn: Biochemical studies in Huntingtons chorea. Neurology 16, 312 (1966).Google Scholar
  237. Hotchin, J.: The biology of lymphocytic choriomeningitis infection: virus-induced immune disease. Cold Spr. Harb. Symp. quant. Biol. 27, 479 (1962).Google Scholar
  238. Hotchin, J., and L. Benson: The pathogenesis of lymphocytic choriomeningitis in mice: The effects of different inoculation routes and the foot-pad response. J. Immunol. 91, 460 (1963).PubMedGoogle Scholar
  239. Hotchin, J., and E. Sikora: Protection against the lethal effect of lymphocytic choriomeningitis virus in mice by neonatal thymectomie. Nature (Lond.) 215, No 4928 (1964).Google Scholar
  240. Howatson, A. F., M. Nagai, and G. M. Rhein: Polyoma-like virions in human demyelinating brain disease. Canad. med. Ass. J. 93, 379 (1965).PubMedGoogle Scholar
  241. Hoyer, L. W., R. M. Condie, and R. A. Good: Prevention of experimental allergic encephalomyelitis with 6-mercaptopurine. Proc. Soc. exp. Biol. (N.Y.) 103, 205 (1960).Google Scholar
  242. Hsu, K. C., R. A. Rifkind, and J. B. Zabriskie: Fluorescent, electron microscopic, and immunoelectrophoretic studies of labeled antibodies. Science 142, No 3598, 1471 (1963).PubMedGoogle Scholar
  243. Huebner, R. J., H. G. Pereira, A. C. Allison, A. C. Hollinshead, and H. C. Turner: Production of type-specific C-antigen in virus-free hamster tumor cells induced by adenovirus type 12. Proc. nat. Acad. Sci. (Wash.) 51, 432 (1964).Google Scholar
  244. Hughes, L. E., and B. Lytton: Antigenic properties of human tumours delayed cutaneous hypersensitivity reactions. Brit. med. J. 1964 I, 209.Google Scholar
  245. Humphrey, J. H., and R. G. White: Immunology for students of medicine. Oxford: Blackwell Scientific 1964.Google Scholar
  246. Hunter, W. M., and F. C. Greenwood: A radio-immunoelectrophoretic assay for human growth hormone. Biochem. J. 91, 43 (1964).PubMedGoogle Scholar
  247. Huxley, J.: Krebs in biologischer Sicht. (Biological aspects of cancer.) Dtsch. TUbersetzung von Dr. Chr. Landschütz and Chr. Landschütz, München. Stuttgart: Georg Thieme 1960.Google Scholar
  248. Hyden, H., and B. Mcewen: A glial protein specific for the nervous system. Proc. Nat. Acad. Sci. 55, 354 (1966).PubMedGoogle Scholar
  249. Ikuta, F., and H. M. Zimmerman: Virus particles in reactive cells induced by intracerebral implantation of dibenzanthracene. J. Neuropath. exp. Neurol. 24, 225 (1965).PubMedGoogle Scholar
  250. Iraci, G., & A. Carteri: Frequenza di gruppi ABO nei tumori intracranici di orgine neuroectodermica. Tumori 50, Nr 3 (1964a).Google Scholar
  251. Iraci, G., & A. Carteri: ABO blood groups in intracranial tumors of neuroectodermal origin. Tumori 50, 187 (1964b).PubMedGoogle Scholar
  252. Iraci, G., A. Carteri & G. G. Toffolo: Frequenza del fattore Rh nei tumori intracranici: studio statistico su 1464 casi. Ann. Neurol. Psichiat. 58, Fasc. I (1964a).Google Scholar
  253. Iraci, G., & G. G. Toffolo: Frequenza dei gruppi ABO nei meningiomi. Tumori 50, Nr 6 (1964b).Google Scholar
  254. Iraci, G., & G. G. Toffolo: Frequenza dei gruppi ABO negli adenomi ipofisari. Tumori 50, Nr 6 (1964c).Google Scholar
  255. Irvine, D. G., and H. Miyashita: Blood types in relation to depressions and schizophrenia: a preliminary report. Canad. med. Ass. J. 92, 551 (1965).PubMedGoogle Scholar
  256. Isliker, H., B. le Maire, and C. Morgan: The use of ferritin-conjugated antibody-fragments in electron-microscopic studies of viruses. Path. et Microbiol. (Basel) 27, 521 (1964).Google Scholar
  257. Itoh, T., and Ch. M. Southam: Isoantibodies to human cancer cells in healthy recipients of cancer homo-transplants. J. Immnuol 91, No 4 (1963).Google Scholar
  258. Ivankovic, S., H. Druckrey & R. Preussmann: Erzeugung von Tumoren im peripheren and zentralen Nervensystem durch Trimethylnitroso-Harnstoff an Ratten. Z. Krebsforsch. 66, 541 (1965).Google Scholar
  259. Jankovic, B. D., and M. Isvaneski: Experimental allergic encephalomyelitis in thymectomized, bursectomized and normal chickens. Int. Arch. Allergy 23, 188 (1963).PubMedGoogle Scholar
  260. Jankovic, B. D., M. Draskoci, D. Paunovic, and L. Popeskovic: Suppression of experimental allergic encephalomyelitis in rats and chickens treated with reserpine. Nature (Lond.) 204, 1101 (1964).Google Scholar
  261. Jankovic, B. D., M. Draskoci, and M. Janjic: Passive transfer of allergic encephalomyelitis with antibrain serum injected into the lateral ventricle of the brain. Nature (Lond.) 207, 428 (1965).Google Scholar
  262. Jankovic, B. D., M. Draskoci, and K. Isakovic: Antibody response in rabbits following injection of sheep erythrocytes into lateral ventricle of brain. Nature (Lond.) 191, 288 (1961).Google Scholar
  263. Jankovic, B. D., and S. Lesrowitz: Restoration of antibody producing capacity in bursectomized chickens by bursal grafts in millipore chambers. Proc. Soc. exp. Biol. (N.Y.) 118, 1164 (1965).Google Scholar
  264. Jarett, L., P. E. Lacy, and D. M. Kipnis: Characterization by immunofluorescence of an ACTH-like substance in nonpituitary tumors from patients with hyperadrenocorticism. J. clin. Endocr. 24, 543 (1964).PubMedGoogle Scholar
  265. Jawetz, E., J. L. Melnick & E. A. Adelberg: Medizinische Mikrobiologie. Berlin-Göttingen-Heidelberg: Springer 1963.Google Scholar
  266. Jellinger, K., & F. Seitelberger: Akute tödliche Entmarkungs-Encephalitis nach wiederholten Hirntrockenzellen-Injektionen. Klin Wschr. 1958, 437.Google Scholar
  267. Jensen, K., J. Clausen, and E. Ostermann: Serum and cerebrospinal fluid proteins in schizophrenia. Acta psychiat. scand. 40, 280 (1964).PubMedGoogle Scholar
  268. Joffe, S., M. M. Rapport, and L. Graf: Identification of an organ specific lipid hapten in brain. Nature (Lond.) 198, No 4862, 60 (1963).Google Scholar
  269. Johnson, A. C., A. R. Mcnabb, and R. J. Rossiter: Concentration of lipids in brain of infants and adults. Biochem. J. 44, 494 (1949).Google Scholar
  270. Johnstone, M. C. (ed.), D. B. Amos, and C. A. Stetson jr.: Tumor immunity. Ann. N.Y. Acad. Sci. 101, 1 (1962).Google Scholar
  271. Kabat, E. A., A. Wolf, and A. E. Bezer: Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys. III. J. exp. Med. 88, 417 (1948).PubMedGoogle Scholar
  272. Kaklamanis, E., E. J. Holborow, and L. E. Glynn: A method for differentiating homozygous secretions of ABH bloodgroup substances. Its application to the study of secretor status in rheumatic fever. Lancet 1964, I 788.Google Scholar
  273. Kandutsch, A. A., and J. H. Stimpfling: Partial purification of isoantigens from a mouse sarcoma. Transplantation 1, No 2 (1963)Google Scholar
  274. Karrer, K., & P. Speiser: Zur Frage der Immunologie von Tumoren. Wien. klin. Wschr. 76, 843 (1964).Google Scholar
  275. Katsh, S., and G. F. Katsh: Aspermatogenic antigen from brain. Experientia (Basel) 21, 442 (1965).Google Scholar
  276. Kelly, R. T., and D. Greiff: Neuraminidase and neuraminidase-labile substrates in experimental influenzavirus encephalitis. Biochim. biophys. Acta (Amst.) 110, 548 (1965).Google Scholar
  277. Kerekes, M. F., T. Feszt, and A. Kovacs: Catheptic activity in the cerebral tissue of the rabbit during allergic encephalomyelitis. Experientia (Basel) 21, 42 (1965).Google Scholar
  278. Kibler, R. F., R. H. Fox, and R. Shapira: Isolation of highly purified encephalitogenic protein from bovine cord. Nature (Lond.) 204, 1273 (1964).Google Scholar
  279. Kies, W. M., and E. C. Alvord: Encephalitogenic activity in guinea pig of water-soluble protein fractions of nervous tissue. In: “Allergic” encephalomyelitis. Springfield, Ill.: Ch. C. Thomas Publ. 1959.Google Scholar
  280. Kies, W. M., E. C. Alvord, R. E. Martenson, and F. N. Le Baron: Encephalitogenic activity of bovine basic proteins. Science 151, 821 (1966).PubMedGoogle Scholar
  281. Kies, W. M., R. H. Laatsch, O. L. Silva, and E. C. Alvord: Chemical and immunological studies on myelin from guinea pig brain. In: Demyelinisierende Encephalomyelitis (E. Pette und H. Bauer, Hrsg.). Stuttgart: Fischer 1964.Google Scholar
  282. Kies, W. M., J. B. Murphy, and E. C. Alvord: Studies on the encephalitogenic factor in guinea pig central nervous system. In: Chemical pathology of the nervous system (edit. by Folch-PI). New York: Pergamon Press 1961.Google Scholar
  283. Kim, Z., G. Uhlenbruck: Untersuchungen über T-Antigen und T-Agglutinin. Z. Immunforsch. 130, 88 (1966).Google Scholar
  284. Klein, P., P. Burkholder: Ein Verfahren zur fluoreszenzoptischen Darstellung der Komplementbindung und seine Anwendung zur histo-immunologischen Untersuchung der experimentellen Nierenanaphylaxie. Dtsch. med. Wschr. 45, 2001 (1959).Google Scholar
  285. Klein, E., and G. Klein: Antigenic properties of lymphomas induced by the Moloney agent. J. nat. Cancer Inst. 32, No 3 (1964).Google Scholar
  286. Klenk, E., W. Gielen: Über ein chromatographisch einheitliches hexosaminhaltiges Gangliosid aus Menschengehirn. Hoppe-Seylers Z. physiol. Chem. 326, 158 (1961).PubMedGoogle Scholar
  287. Klenk, E., U. W. Hendricks D. W. Gielen: D-Galaktosido-(1–3)-N-acetyl-n-galaktosamin, ein kristallisiertes Disaccharid aus menschlichen Gehirngangliosiden. Hoppe-Seylers Z. physiol. Chem. 330, 140 (1962).PubMedGoogle Scholar
  288. Klenk, E., K. Heuer: Über die Ganglioside der Hundeerythrocyten. Dtsch. Z. Verdau.- u. Stoffwechselkr. 20, 180 (1960).Google Scholar
  289. Klenk, E., W. Kahlre: Über das Vorkommen der 3.7.11.15-Tetramethyl-hexadecansäure (Phytansäure) in den Cholesterinestern und anderen Lipoidfraktionen der Organe bei einem Krankheitsfall unbekannter Genese [Verdacht auf Heredopathia atactica polyneuritiformis (Refsum-Syndrom)]. Hoppe-Seylers Z. physiol. Chem. 333, 133 (1963).PubMedGoogle Scholar
  290. Koch, FR.: Encephalitis postvaccinalis und Vorimpfung mit Vakzine-Antigen (Herrlich). Dtsch. med. Wschr. 88, 1937 (1963).PubMedGoogle Scholar
  291. Koffler, D., and M. Fogel: Immunofluorescent localization of LH and FSH in the human adenohypophysis. Proc. Soc. exp. Biol. (N.Y.) 115, 1080 (1964).Google Scholar
  292. Kolar, O.: Die subakuten Enzephalitiden (Dawson-Pette-Döring-Bogaert). Z. ärztl. Fortbild. 59, 262 (1965).Google Scholar
  293. Kolar, O., L. Behounkova: Zur immunopathologischen Problematik der subakuten sklerosierenden Leukoencephalitis. Psychiat. Neurol. med. Psychol. (Lpz.) 16, 274 (1964).Google Scholar
  294. Kolar, O., L. Behounkova, U. Hasskova-Messner: Die verzögerte Hypersensitivität (delayed hypersensitivity) in der Pathogenese der subakuten Panenzephalitiden. Acta Univ. Palack. Olomuc. 34, 295 (1964).Google Scholar
  295. Koprowski, H.: Fortschritte der Tumorvirusforschung. Triangel Sandoz 6, 1 (1964).Google Scholar
  296. Koprowski, H., and M. V. Fernandes: Autosensitization reaction in vitro. Contactual agglutination of sensitized lymph-node cells in brain tissue culture accompanied by destruction of glial elements. In: Cell bound antibodies. Philadelphia: Wistar Inst. Press 1963.Google Scholar
  297. Korey, S. R., R. Katzman, and J. Orloff: A case of Jakob-Creutzfeldt disease. J. Neuropath. exp. Neurol. 20, 95 (1961).PubMedGoogle Scholar
  298. Kornguth, S. E., and J. W. Anderson: Localization of a basic protein in the myelin of various species with the aid of fluorescence and electron microscopy. J. Cell Biol. 26, 157 (1965).PubMedGoogle Scholar
  299. Kornguth, S. E., J. W. Anderson, and H. G. Thompson jr.: Stimulation of lymph node protein synthesis by a basic protein from brain. Arch. Biochem. 105, 308 (1964).Google Scholar
  300. Kort, J.: Probleme der Transplantation. Dtsch. med. Wschr. 89, 1903 (1964).Google Scholar
  301. Koscielak, J.: ABo Blood group substances from erythrocytes as “lipid” antigens. Bibliotheca Haematol. 32, 453 (1965).Google Scholar
  302. Kovacs, E.: Aktivitätshemmung der 5-Nucleotidase durch Abbauprodukte von mit Schlangengift verdauten Hirsebrei und Lecithin. Z. Vitamin-, Hormon-u. Fermentforsch. 11, 325 (1960).Google Scholar
  303. Kracht, J., H. D. Zimmermann, U. Hachmeister: Immunhistologischer ACTH-Nachweis in einem R-Zellen-Adenom des Hypophysenvorderlappens bei M. Cushing. Virchows Arch. path. Anat. 340, 270 (1966).Google Scholar
  304. Krementz, E. T., and H. S. N. Greene: Heterologous transplantation of human neural tumors. Cancer 6, 100 (1953).PubMedGoogle Scholar
  305. Kullander, S.: The development of hypophyseal, ovarian and mammary gland tissues grafted simultaneously to the anterior chamber of the eye or the spleen of gonadectomized rats. Acta obstet. gynec. scand. 44, 89 (1965).PubMedGoogle Scholar
  306. Kunert, H., & H. Schleussing: Experimentelle Untersuchungen zur Genese der postvakzinalen Enzephalomyelitis bei bestehender Toxoplasma-Infektion. Arch. Hyg. (Berl.) 149, 133 (1965).Google Scholar
  307. Kurtzke, J. F.: Familiar incidence and geography in multiple sclerosis. Acta neurol. scand. 41, 127 (1965a).PubMedGoogle Scholar
  308. Kutscea, W.: Die Funktion der motorischen Endplatte. Dtsch. med. Wschr. 88, 331 (1963).Google Scholar
  309. Kuwert, E., and B. Niedieck: Anti-cerebroside antibodies in cerebrospinal fluid of rabbits with experimental “allergic” encephalomyelitis. Nature (Lond.) 207, 991 (1965).Google Scholar
  310. Kuwert, E., W. Firnhaber, K. Mai & E. Pette: Komplementsystem und Liquor cerebrospinalis. I. Methodik und Bezugswerte. Z. Immun - u. Allerg.-Forsch. 127, 321 (1964).Google Scholar
  311. Kyogoku, M., Y. Yagi, J. Planinsek, J. Bernecky, and D. Pressman: Localizing properties of anti-rat hepatoma antibodies in vivo. Cancer Res. 24, 268 (1964).PubMedGoogle Scholar
  312. Lachmann, P. J., K. W. Sell, and R. L. Spooner: The mixed conglutination reaction. Immunology 8, 345 (1965).PubMedGoogle Scholar
  313. Lampert, P., and S. Carpenter: Electron microscopic studies on the vascular permeability and the mechanism of demyelination in experimental allergic encephalomyelitis. J. Neuropath. exp. Neurol. 24, 11 (1965).PubMedGoogle Scholar
  314. Lang, N.: Immunologie des Karzinoms als Grundlage therapeutischer Überlegungen. Med. Welt 1963, 2538.Google Scholar
  315. Laron, Z., B. Z. Arie, and S. Assa: The immunological properties of human ACTH. Acta endocr. (Kbh.) 45, Suppl. 89, 12 (1964a).Google Scholar
  316. Laron, Z., A. Yed-Lekach, A. Kowaldo-Silbergeld, and S. Assa: The immunological properties of growth hormone after enzyme hydrolysis and heating. Acta endocr. (Kbh.) 45, Suppl. 89, 12 (1964b).Google Scholar
  317. Lawrence, H. S.: Transfer factor and autoimmune disease. Ann. N.Y. Acad. Sci. 124, 65 (1965).Google Scholar
  318. Lawrence, H. S.: Some biological and immunological properties of transfer factor. In: Ciba Foundation Symposion on Cellular Aspects of Immunity, p. 243 (1960).Google Scholar
  319. Lawrence, H. S.: The transfer of hypersensitivity of the delayed type in man. In: Cellular and humoral aspects of the hypersensitive states (H. S. Lawrence, ed.). New York: Paul B. Hoeber Inc. 1959.Google Scholar
  320. Le Baron, F. N.: Neurochemistry. Ann. Rev. Biochem. 28, 579 (1960).Google Scholar
  321. Le Baron, F. N.: The nature of the linkage between phosphoinositides and proteins in brain. Biochim. biophys. Acta (Amst.) 70, 658 (1963).Google Scholar
  322. Le Baron, F. N., and J. Folch: The isolation from brain tissue of a trypsin-resistant protein fraction containing combined inositol and its relation to neurokeratin. J. Neurochem. 1, 101 (1956).Google Scholar
  323. Lecks, H. I., and D. Baker: Pseudotumor cerebri. An allergic phenomenon? Clin. Pediatrics 4, No 1 (1965).Google Scholar
  324. Le Cocq, J., and E. Ballou: On the structure of cardiolipin. Biochemistry 3, 976 (1964).Google Scholar
  325. Lederer, E.: Biogenese, Struktur und biologische Wirkungen der Lipoide des Tuberkelbazillus. Angew. Chem. 76, 241 (1964).Google Scholar
  326. Lee, J. M.: Proteolipid as an incitant of “allergic” encephalomyelitis in mice. In: “Allergic” encephalomyelitis. Springfield, Ill.: Ch. C. Thomas Publ. 1959.Google Scholar
  327. Lee, M. B., S. Carr, and J. Folch: Purification of bovine brain white matter proteolipids by dialysis in organic solvents. Biochim. biophys. Acta (Amst) 84, 464 (1964).Google Scholar
  328. Lehmann-Grube, F.: Lymphocytic choriomeningitis in the mouse. I. Arch. ges. Virusforsch. 14, 344 (1964a).Google Scholar
  329. Lehmann-Grube, F.: Lymphocytic choriomeningitis in the mouse. II. Arch. ges. Virusforsch. 14, 351 (1964b).Google Scholar
  330. Leibowitz, E., and R. K. Brown: Production of antibodies to ACTH peptide in rabbits. Ann. Pept. Div. Lab. Res. 1963, 58.Google Scholar
  331. Lerner, M. E., and V. H. Haas: Histopathology of lymphocytic choriomeningitis in mice spared by amethopterin. Proc. Soc. exp. Biol. (N.Y.) 98, 395 (1958).Google Scholar
  332. Levey, R. H., N. Trainin, L. W. Law, P. H. Black, and W. P. Rowe: Lymphocytic choriomeningitis infection in neonatally thymectomized mice bearing diffusion chambers containing thymus. Rep. Sci. 142, 483 (1963).Google Scholar
  333. Levi, E., and A. M. Schechtmann: The preparation in immunologically tolerant rabbits of antisera against Ehrlich ascites tumor. Cancer Res. 23, 1566 (1963).PubMedGoogle Scholar
  334. Levi-Montalcini, R.: The nerve growth factor. Ann. N.Y. Acad. Sci. 118, 149 (1964).PubMedGoogle Scholar
  335. Levi-Montalcini, R.: Biological aspects of specific growth promoting factors. Proc. roy. Soc. Med. 58, 357. (1965)PubMedGoogle Scholar
  336. Levine, S., H. Payan, and R. Strebel: Metrazol threshold in experimental allergic encephalomyelitis. Proc. Soc. exp. Biol. (N.Y.) 113, 901 (1963).Google Scholar
  337. Levine, S., and E. J. Wenk: Allergic neuritis induced in rats without the use of mycobacteria. Proc. Soc. exp. Biol. (N.Y.) 113, 898 (1963a).Google Scholar
  338. Levine, S., and E. J. Wenk: Encephalitogenic potencies of nervous system tissue. Proc. Soc. exp. Biol. (N.Y.) 114, 220 (1963b).Google Scholar
  339. Levine, S., and E. J. Wenk: Allergic encephalomyelitis: A hyperacute form. Science 146, No 3652, 1681 (1964).PubMedGoogle Scholar
  340. Levine, S., and E. J. Wenk: A hyperacute form of allergic encephalomyelitis. Amer. J. Path. 47, 61 (1965).Google Scholar
  341. Levine, S., and E. J. Wenk: Passive transfer of allergic encephalomyelitis: Acceleration by adrenalectomy. Proc. Soc. exp. Biol. (N.Y.) 121, 301 (1966).Google Scholar
  342. Levine, S., E. J. Wenk, M. W. Kies, and E. C. Alvord: Central nervous tissue system: is it an immunological adiuvant? Neurology (Minneap.) 15, 560 (1965).Google Scholar
  343. Levy, H. B., and V. H. Haas: Alteration of the course of lymphocytic choriomeningitis in mice by certain antimetabolites. Virology 5, 401 (1958).PubMedGoogle Scholar
  344. Lewis, J. H.: The immunologic specificity of brain tissue J Immunol. 24, 193 (1933).Google Scholar
  345. Lewis, J. H.: The iso-antigenic properties of alcoholic extracts of brain. J. Immunol. 41, 397 (1941).Google Scholar
  346. Liebold, F., D. Biesold & G. Focke: Untersuchungen über die Wirkung von Gallenfarbstoffen auf Mitochondrien in vitro. Acta biol. med. germ. 12, 421 (1964).PubMedGoogle Scholar
  347. Link, H.: Isolation and partial characterization of “trace” proteins and immunoglobulin G from cerebrospinal fluid. J. Neurol. Neurosurg. Psychiat. 28, 552 (1965).PubMedGoogle Scholar
  348. Lipp, R.: Untersuchungen über die biologischen Eigenschaften maligner Gewebe und Zellen in vitro. Oncologia (Basel) 19, 353 (1965).Google Scholar
  349. Lipton, M. M.: The role of adjuvans in the rapid production of experimental “allergic” encephalomyelitis. In: “Allergic” encephalomyelitis. Springfield, Ill.: Ch. C. Thomas Publ. 1959.Google Scholar
  350. Lipton, M. M.: In: “Allergic” encephalomyelitis, Chapt. 13, p. 300–303. Springfield (Ill.): Ch. C. Thomas 1959.Google Scholar
  351. Lipton, M. M. and J. Freund: The transfer of experimental allergic encephalomyelitis in the rat by means of parabiosis. J. Immunol. 71, 380 (1953).PubMedGoogle Scholar
  352. Ljungdahl, I., R. R. Strang, and D. Tovi: Intracerebral Hodgkins granuloma. Neurochirurgia (Stuttg.) 8, 113 (1965).Google Scholar
  353. Loewenthal, A.: Agar gel electrophoresis in neurology. New York: Elsevier Publ. 1964.Google Scholar
  354. Lumsden, C. E.: Experimental “allergic” encephalomyelitis. Brain 72, 198 (1949).PubMedGoogle Scholar
  355. Lumsden, C. E.: II. On the nature of the encephalitogenic agent. Brain 72, 517 (1949).Google Scholar
  356. Lumsden, C. E., D. M. Robertson, and R. Bright: New and unexpected finduings on the chemical natre of the ECM-promoting factor(s) in bovine spinal cord. In: Demyelinisierende Encephalomyelitis (Pette und Bauer). Stuttgart: Gustav Fischer 1964.Google Scholar
  357. Lumsden, C. E., D. M. Robertson, and R. Bright: Chemical studies on experimental allergic encephalomyelitis. Peptide as the common denominator in all encephalitogenic “antigens”. J. Neurochem. 13, 127 (1966).PubMedGoogle Scholar
  358. Lytton, B., L. E. Hughes, and A. J. Fulthorpe: Circulating antibody response in malignant disease. Lancet 1964 I, 69.Google Scholar
  359. Macfarlane, M. G.: The structure of cardiolipin. Biochem. J. 92, 120 (1964).Google Scholar
  360. Macpherson, C. F. C., and A. Liakopoulou: Studies on brain antigens. J. Immunol. 97, 450 (1966).PubMedGoogle Scholar
  361. Macpherson, C. F. C., and M. Saffran: An albumin and a-globulin characteristic of bovine cerebrospinal fluid. J. Immunol. 95, 629 (1965).PubMedGoogle Scholar
  362. Maeder, E.: Untersuchungen mit natürlichem und synthetischem ACTH bei ACTH-Allergikern. Int. Arch. Allergy, Suppl. 24, 27 (1964).Google Scholar
  363. Maeder, E. & M. Schwarz-Speck: Allergieteste mit natürlichem und synthetischem ACTH. Dermatologica (Basel) 129, 59 (1964).Google Scholar
  364. Maguire, H. C., H. I. Maibach, and L. W. Minisce: Inhibition of guinea pig anaphylactic sensitization with cyclophosphoramide. J. invest. Derm. 36, 255 (1961).Google Scholar
  365. Mahaley, M. S., and E. D. Day: Immunological studies of human gliomas. J. Neurosurg. 23, 363 (1965).PubMedGoogle Scholar
  366. Mahaley, M. S., J. L. Mahaley, and E. D. Day: The localisation of radioantibodies in human brain tumors. II. Radio-autography. Cancer Res. 25, 865 (1965).Google Scholar
  367. Makita, A.: Biochemistry of organ glycolipids. II. Isolation of human kidney glycolipids. J. Biochem. (Tokyo) 55, No 3 (1964).Google Scholar
  368. Makita, A., and T. Yamakawa: Biochemistry of organ glycolipids. I. Ceramide-oligohexosides of human equine and bovine spleens. J. Biochem. (Tokyo) 51, 124 (1962).Google Scholar
  369. Makita, A., and T. Yamakawa: Biochemistry of organ glycolipids. III. The structures of human kidney cerebroside sulfuric ester, ceramide dihexoside and ceramide trihexoside. J. Biochem. (Tokyo) 55, No 4 (1964).Google Scholar
  370. Malkiel, S., and B. J. Hargis: Anaphylaxis in mice inoculated with an adrenotrophic pituitary tumor. Int. Arch. Allergy 26, 319 (1965).PubMedGoogle Scholar
  371. Mancini, A. M., G. Constanzi, V. Tison, and S. Levin: Antigenicity of the human arachnoid. Lancet 1964 II, 1295.Google Scholar
  372. Marquardt, H.: Neue experimentelle Ergebnisse zur Mutationshypothese der chemisch induzierten krebsigen Entartung. Dtsch. med. Wschr. 90, 398 (1965).Google Scholar
  373. Martin, J.: The transplantation of human brain tumors into animal hosts. J. Neuropath. exp. Neurol. 10, 40 (1951).PubMedGoogle Scholar
  374. Mathe, G., & J. L. Amiel: L’immunothérapie. Nouvelle méthode de traitement des leucémies. Nouv. Rev. franç. Hémat. 4, 211 (1964).Google Scholar
  375. Matsuda, K., C. Duyck, and M. A. Greer: Restoration of the ability of rat pituitary homotransplants to secrete ACTH if placed under the hypothalamic. Endocrinology 74, 939 (1964).PubMedGoogle Scholar
  376. Matthews, W. B.: Sarcoidosis of the nervous system. J. Neurol. Neurosurg. Psychiat. 28, 23 (1965).PubMedGoogle Scholar
  377. Matussek, N.: Biochemie and Schizophrenie. Dtsch. med. Wschr. 89, 1268 (1964).Google Scholar
  378. Maurer, F. D.: Lymphocytic choriomeningitis. Laboratory animal care 14, 415 (1964).PubMedGoogle Scholar
  379. Mayr, E., L. K. Diamond, R. P. Levine, and M. Mayr: Suspected correlation between blood group frequencies and pituitary adenoma. Science 124, 932 (1956).PubMedGoogle Scholar
  380. Mcalpine, D., C. E. Lumsden, and E. D. Aciieson: Multiple sclerosis. A reappraisal. VIII, 415 p. London and Edinburgh: E. & S. Livingstone 1965.Google Scholar
  381. Mccallion, D. J., and J. Langman: An immunological study on the effect of brain extract on the developing nervous tissue in the chick embryo. J. Embryol. exp. Morph. 12, 77 (1964).Google Scholar
  382. Mcdevitt, H. O., J. H. Peters, L. W. Pollard, J. G. Harter, and A. H. Coons: Purification and analysis of fluorescein-labeled antisera by column chromatography. J. Immunol. 90, No 4 (1963).Google Scholar
  383. Mcduffie, F. C.: Transplantation immunity. Arthr. and Rheum. 7, 87 (1964).Google Scholar
  384. Mcgarry, E. E., L. Ambe, Nayak, E. Birch, and J. C. Beck: Studies with antisera to pituitary hormones. Metabolism 13, 1154 (1964).PubMedGoogle Scholar
  385. Mckenna, J. M., R. S. Sanderson, and W. S. Blakemore: Studies of the antigens of human tumors. Demonstration of a soluble specific antigen in HeLa cells and some human tumors. Cancer Res. 24, 754 (1964).PubMedGoogle Scholar
  386. Medawar, P. B.: Immunity to homologous grafted skin. III. Fate of skin homografts transplanted to brain, to subcutaneous tissue, and to anterior chamber of eye. Brit. J. exp. Path. 29, 58 (1948).PubMedGoogle Scholar
  387. Mellanby, J., W. E. van Heyningen, and V. P. Whittaker: Fixation of tetanus toxin by subcellular fractions of the brain. J. Neurochem. 12, 77 (1965).PubMedGoogle Scholar
  388. Metzger, J. F., and CH. W. Smith: The application of immune electron microscopy to the demonstration of antigenic sites in biologic systems. Lab. Invest. 1963, 902.Google Scholar
  389. Michaelis, R. H., M. M. Weinberger, and Monto Ho: Circulating interferon-like viral inhibitor in patients with meningitis due to Haemophilus influenzae. Rep. from the New Engl. J. Med. 272, 1148 (1965).Google Scholar
  390. Mihailovi, LT., B. D. Jankovic, B. Beleslin, D. MILosEvic, and D. CUPIC: Effects of anti-lobster nerve antibody on membrane potentials of the giant axon of Palinurus vulgaris. Nature (Lond.) 206, 904 (1965).Google Scholar
  391. Milgrom, F.: A short of immunological investigations on cancer. Cancer Res. 21, 862 (1961).PubMedGoogle Scholar
  392. Milgrom, F.: The unusual serology of syphilis, infectious mononucleosis and rheumatoid arthritis. Transfusion (Philad.) 4, 407 (1964).Google Scholar
  393. Milgrom, F., W. A. Campbell, and E. Witebsky: Studies on immunisation with organspecific haptens. Proc. Soc. exp. Biol. (N.Y.) 115, 165 (1964).Google Scholar
  394. Milgrom, F., M. Tuggac, W. A. Campbell, and E. Witebsky: Thermostable ethanol-insoluble antigens of brain. J. Immunol. 92, 82 (1964).PubMedGoogle Scholar
  395. Milgrom, F., M. Tuggac, and E. Witebsky: Studies on species specifity. J. lmmunol. 93, No 6 (1964).Google Scholar
  396. Milgrom, F., M. Tuggac, and E. Witebsky: Organ-specific antigens of liver, testicle and pituitary. J. Immunol. 94, No 1 (1965).Google Scholar
  397. Miller, J. F. A. P., & P. Dukor: Die Biologie des Thymus. Frankfurt a. M.: Akademische Verlagsgesellschaft 1964.Google Scholar
  398. Mitrovic, K., M. Draskoci, and B. D. Jankovic: Antibody production in rabbits following immunization via lateral ventricle of the brain. Experientia (Basel) 20, 700 (1964).Google Scholar
  399. Mitts, M. G., and A. E. Walker: Autoimmune response to malignant glial tumors. Neurology (Minneap.) 15, 474 (1965).Google Scholar
  400. Möller, G.: Studies on the mechanism of immunological enhancement of tumor homografts. I. Specificity of immunological enhancement. J. nat. Cancer Inst. 30, 1153 (1963).Google Scholar
  401. Möller, G.: Studies on the mechanism of immunological enhancement of tumor homografts. II. Effects of isoantibodies on various tumor cells. J. nat. Cancer Inst. 30, No 6 (1963).Google Scholar
  402. Möller, G.: Studies on the mechanism of immunological enhancement of tumor homografts. III. Interaction between tumor isoantibodies and immune lymphoid cells. J. nat. Cancer Inst. 30, No 6 (1963).Google Scholar
  403. Mollaret, P., J. Delay, P. Burtin, & Th. Lemperiere: Dosage immunochimique des gammaglobulines du lipoide cephalo-rachidien dans les maladies mentales. Path. et Biol. 14, 1 (1956).Google Scholar
  404. Monseau, G., and J. N. Ctmings: Polyacrylamide disc electrophoresis of the proteins of cerebrospinal fluid and brain. J. Neurol. Neurosurg. Psychiat. 28, 56 (1965).Google Scholar
  405. Moore, B. W.: A soluble protein characteristic of the nervous system. Biochem. biophys. Res. Commun. 19, 739 (1965).Google Scholar
  406. Moore, B. W., and D. Mcgregor: Chromatographic and electrophoretic fractionation of soluble proteins of brain and liver. J. biol. Chem. 240, 1647 (1965).PubMedGoogle Scholar
  407. Moore, R. D., M. E. Lamm, L. A. Lockman, and M. D. Schoenberg: Cellular aspects of the action of Freund’s adjuvans in the spleen and lymph nodes. Brit. J. exp. Path. 44, 300 (1963).Google Scholar
  408. Mori, H., H. Nakai, and T. Nozima: The interaction of japanese encephalitis virus with its receptor prepared from pigeon red blood cells and susceptible cells. Acta virol. 9, 97 (1965).PubMedGoogle Scholar
  409. Morris, H. G., Y. Arai, C. J. Hlad, R. Tompkins, and H. Elrick: Rapid quantitative immunologic assay of human growth hormone. J. clin. Endocr. 24, 417 (1964).PubMedGoogle Scholar
  410. Morrison, R. L., and P. C. Zamecnik: Experimental demyelination by means of enzymes especially the alpha toxin of Clostridium welchii. Arch. Neurol. Psychiat. (Chic.) 63, 367 (1950).Google Scholar
  411. Moss, N. H.: Unusual forms and aspects of cancer in man. Ann N Y Acad. Sci. 114, 717 (1964).Google Scholar
  412. Mueller, P., M. W. Kies, E. C. Alvord, and R. S. Yamamoto: Effect of experimental allergic encephalomyelitis on guinea pig plasma lipid fractions. Proc. Soc. exp. Biol. (N.Y.) 115, 1095 (1964).Google Scholar
  413. Munoz, J.: Effect of bacteria and bacterial products on antibody response Immunology 4, 397 (1964).Google Scholar
  414. Mur, J.: Analytische Reagenzstoffe im neuro/pathologischen Versuch. Confin. neurol. (Basel) 24, 235 (1964).Google Scholar
  415. Nelson, D. S.: Immuneadherence. Advanc. Immunol. 3, 131 (1964).Google Scholar
  416. Newbould, B. B.: Production of allergic encephalomyelitis in rats by injections of spinal cord adjuvants into the inguinal lymph nodes. Immunology 9, 613 (1965).Google Scholar
  417. Niedieck, B.: Zur Frage der Lipidhaptene des Nervensystems. In: Demyelinisierende Encephalomyelitis, S. 40. Stuttgart: Gustav Fischer 1964.Google Scholar
  418. Niedieck, B., O. Drees & E. Kuwert: Zur Serologie der Experimentellen Allergischen Encephalomyelitis. II. Charakterisierung der gegen das Cerebrosidhapten gerichteten Antikörper in der Ultrazentrifuge und in der Immunelektrophorese. Z. Immun.-Forsch. 128, 201 (1965).Google Scholar
  419. Niedieck, B., & E. Kuwert: Zur Serologie der experimentellen allergischen Encephalomyelitis. I. Vergleich der Reaktivität von Lipidgemischen und Myelinextrakten mit den entsprechenden Antiseren im Präzipitationstest und in der Komplementbindungsreaktion. Z. Immun -Forsch. 155, 470 (1963).Google Scholar
  420. Niedieck, B., & O. Palacios: Tuber die Produktion von Cerebrosidantikörpern nach intradermaler Injektion von Cerebrosid-Protein-Adjuvans-Emulsionen. Z, Immun - u. Allergieforsch. 129, 234 (1965).Google Scholar
  421. Niedieck, B., & E. Pette: Immunchemische Untersuchungen zur Identifizierung eines äthanollöslichen Myelinhaptens. Klin. Wschr. 41, 773 (1963).PubMedGoogle Scholar
  422. North, E. A., G. Pawlyszyn, and H. M. Doery: The action of phosphatidase A, sodium oliate and ganglio-side on the exotoxins of Cl. welchii and on the neurotoxins of Shigella shigae. Aust. J. exp. Biol. med. Sci. 39, 259 (1961).Google Scholar
  423. O’Brien, J. S.: A molecular defect of myelination. Biochem. biophys. Res. Commun. 15, 484 (1964).Google Scholar
  424. O’Brien, J. S.: Stability of the myelin membrane. Science 147, 1099 (1965).PubMedGoogle Scholar
  425. O’Brien, J. S., D. L. Fillerup, and J. F. Mead: Quantification of fatty acid and fatty aldehyde composition of ethanol-amine, choline, and serine glycerophosphatides in human cerebral grey and white matter. J. Lipid Res. 5, 329–338 (1964).PubMedGoogle Scholar
  426. O’Connor, J. F., and D. Musher: Central nervous system involvement in systemic lupus erythematosus. Arch. Neurol. (Chic.) 14, 157 (1966).Google Scholar
  427. O’Gorman, P.: Auto-immune disease. Guy’s Hosp. Rep. 1963, Bd. 112/3, S. 402.Google Scholar
  428. Oravec, C.: Interaction of properdin system with tumorous cells. Neoplasma (Bratisl.) 11, 1 (1964).Google Scholar
  429. Osterhuis, H. J. G. H., H. van der Geld, T. E. W. Feltkamp, and F. Peetoom: Myasthenia gravis with hypergammaglobulinemia and antibodies. J. Neurol. Neurosurg Psychiat. 27, 345 (1964).Google Scholar
  430. Panda, J. N., H. E. Dale, R. W. Loan, and L. E. Davis: Immunologic response to subarachnoid and intracerebral injection of antigens. J. Immunol. 94, 760 (1965).PubMedGoogle Scholar
  431. Parker, W. C., J. W. C. Hagstrom, and A. G. Bearn: Additional studies on the transferrins of cord serum and cerebrospinal fluid. J. exp. Med. 118, 975 (1963).PubMedGoogle Scholar
  432. Pascal, T. A., A. Saifer, and J. Gitlin: Immunochemical studies on normal and Tay-Sachs brain ganglio-sides. Proc. Soc. exp. Biol. (N.Y.) 121, 739 (1966).Google Scholar
  433. Pasternak, G.: Neue Aspekte der immunologischen Krebsforschung. Dtsch. Gesundh.-Wes. 18, Heft 40 (1963).Google Scholar
  434. Pasternak, G., A. Graffi & K.-H. Horn: Der Nachweis individualspezifischer Antigenität bei UV-induzierten Sarkomen der Maus. Acta biol. med. germ. 13, 276 (1964).PubMedGoogle Scholar
  435. Paterson, P. Y.: Study of experimental encephalomyelitis employing mammalian and nonmammalian nervous tissue. J. Immunol. 78, 472 (1957).PubMedGoogle Scholar
  436. Paterson, P. Y.: Studies of immunological tolerance to nervous tissue in rats. Ann. N.Y. Acad. Sci. 73, 811 (1958).PubMedGoogle Scholar
  437. Paterson, P. Y.: Tolerance to the paralytogenic activity of nervous tissue. In: Allergic encephalomyelitis. Springfield, Ill.: Ch. C. Thomas Publ. 1959.Google Scholar
  438. Paterson, P. Y.: Cellular and humeral immune factors in allergic encephalomyelitis. In: Mechanism of cell and tissue damage produced by immune reactions, p. 184 Basel: Benno Schwabe & Co. 1961.Google Scholar
  439. Paterson, P. Y.: Cell antibodies and auto-immune disease. In: Cell bound antibodies. Philadelphia: Wistar Institute Press 1963.Google Scholar
  440. Paterson, P. Y., and N. E. Beisaw: Effect of whole body X-irradiation on induction of allergic encephalomyelitis in rats. J. Immunol. 90, 532 (1963).PubMedGoogle Scholar
  441. Paterson, P. Y., A. F. Jacobs, and E. M. Coia: Complement-fixing antibrain antibodies and allergic encephalomyelitis. Further studies concerning their protective role. Ann. N.Y. Acad. Sci. 124, 292 (1965).PubMedGoogle Scholar
  442. Paterson, P. Y., and H. S. Weiss: Transfer of allergic encephalomyelitis in rats by intracerebral injection of lymphoid cells. Proc. Soc. exp. Biol. (N.Y.) 119, 627 (1965).Google Scholar
  443. Pattison, I. H., and K. Smith: Experimental scrapie in goats: a modification of incubation period and clinical response following pre-treatment with normal goat brain. Nature (Lond.) 200, 1342 (1963).Google Scholar
  444. Pearson, C. M.: Hypersensitivity mechanisms in man and animals. In: Mechanisms of demyelination, p. 93118. New York: McGraw-Hill Book Co. 1963.Google Scholar
  445. Peck, H. M., A. F. Woodiiour, D. P. Metzgar, S. E. Mckinney, and M. R. Hilleman: New metabolizable immunologic adjuvant for human use. II. Short term animal toxicity tests. Proc. Soc. exp. Biol. (N.Y.) 116, 523 (1964).Google Scholar
  446. Pelner, L.: Host-tumor-antagonism. XXXIII Cancer immunity — a review and an analysis of some factors in host resistance to cancer. J. Amer. Geriat. Soc. 11, No 9 (1963).Google Scholar
  447. Périer, O., and A. Gregoire: Electron microscopic features of multiple sclerosis lesions. Brain 88, 937 (1965).PubMedGoogle Scholar
  448. Petersen, C. E., & H. Doose: Akute hämolytische Anämie durch Autoantikörper mit zerebraler Symptomatik. Tägl. Praxis 5, 249 (1964).Google Scholar
  449. Pette, E., & H. Pette: Die multiple Sklerose — ein immunologisches Problem. Wien. klin. Wschr. 24, 482–485 (1963a).Google Scholar
  450. Pette, E., & H. Pette: Virologische Aspekte bei der multiplen Sklerose. Dtsch. Z. Nervenheilk. 185, 295 (1963b).Google Scholar
  451. Pfeiffer, E. F., & J. P. Merrill: Die Autoaggression in der Pathogenese der diffusen Glomerulonephritis. Dtsch. med. Wschr. 87, 934 (1962).Google Scholar
  452. Phillips, S. M., S. E. Kornguth, and H. G. Thompson: Serum haptoglobin changes in multiple sclerosis. Neurology (Minneap.) 15, 415 (1965).Google Scholar
  453. Pital, A., and S. L. Janowitz: Enhancement of staining intensity in the fluorescent-antibody reaction. J. Bact. 86, 888 (1963).PubMedGoogle Scholar
  454. Popivanov, R., and V. H. Vulchanov: Organ antibodies detected in serum of 0-blood-group-person immunized with spermatozoa of donor belonging to A-bloodgroup. Compt. rend. Acad. bulg. Sci. 17, No 9 (1964).Google Scholar
  455. Poppe, W., u. A. Tennstedt: Die Verbindung der Pickschen Atrophie mit Hirnnervenkernveränderungen und Pyramidenbahnsymptomatik. Acta neuropath. (Berl.) 4, 169–174 (1964).Google Scholar
  456. Poskanzer, D. C., K. Schapira, R. A. Brack, and H. Miller: Studies of blood groups, genetic linkage, trait association, and chromosomal pattern in multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 28, 218 (1965).PubMedGoogle Scholar
  457. Prader, A., H. Wagner, J. Széky, R. Illig, J. L. Tourer, and D. Maingay: Acquired resistance to human growth hormone caused by specific antibodies. Lancet 1964 I, 378.Google Scholar
  458. Prehn, R. T.: Function of depressed immunologic reactivity during carcinogenesis. J. nat. Cancer Inst. 31, No 4 (1963).Google Scholar
  459. Prehn, R. T.: A clonal selection theory of chemical carcinogenesis. J. nat. Cancer Inst. 32, No 1 (1964).Google Scholar
  460. Pritchard, E. T., and J. Folci-Pi: Tightly-bound proteolipid phospholipid in bovine brain white matter. Biochim. biophys. Acta (Amst.) 70, 481 (1963).Google Scholar
  461. Prokop, O., & G. Uhlenbruck: Lehrbuch der menschlichen Blut-und Serumgruppen. Leipzig: VEB Thieme 1966.Google Scholar
  462. Rabotti, G. F., W. A. Raine, and R. L. Sellers: Brain tumors (gliomas) induced in hamsters by Bryan’s strain of Rous sarcoma virus. Science 147, No 3657, 504 (1965).PubMedGoogle Scholar
  463. Rabotti, G. F., R. L. Sellers, and W. A. Anderson: Leptomeningeal sarcomata and gliomata induced in rabbits by Rous sarcoma virus. Nature (Lond.) 209, 525 (1966).Google Scholar
  464. Rajah, P. C., S. Bogoch, M. A. Rushworth, and P. C. Gorrester: Antigenic constituents of basic proteins from human brain. Immunology 11, 217 (1966a).Google Scholar
  465. Rabotti, G. F., and S. Bogoch: Brain antigens: Components of subfractions from human grey matter Immunology 11, 211 (1966b).Google Scholar
  466. Rapport, M. M.: Structure and specificity of the lipid haptens of animal cells. J. Lipid Res. 2, 25 (1961).Google Scholar
  467. Rapport, M. M.: The antigenic properties of sphingolipids. In: J. FoLcu-PI and H. Bauer: Brain lipids and lipoproteins, and the leucodystrophies. Amsterdam/London/New York: Elsevier Publ. 1963.Google Scholar
  468. Rapport, M. M., L. Graf, and H. Schneider: Immunochemical studies of organ and tumor lipids. XIII. Isolation of cytolipin K, a glycosphingolipid hapten present in human kidney. Arch. Biochem. 105, 431 (1964).Google Scholar
  469. Rauch, H. C., and S. Raffelt: Immunfluorescent localization of encephalitogenic protein in myelin J Immunol. 92, 452 (1964a).Google Scholar
  470. Rauch, H. C., and S. Raffelt: Cellular activities in hypersensitive reactions. IV. Specifically reactive cells in delayed hypersensitivity: Allergic encephalomyelitis. J. Immunol. 93, 937 (1964b).Google Scholar
  471. Refsum, S., and L. Tveten: Polyarteritis nodosa with polyneuritis and involvement of the central nervous system: a clinico-pathological report. Psychiat. Neurol. Neurochir. (Amst.) 66, 418 (1963).Google Scholar
  472. Reichner, H.: Zur Frage der serologischen Unterscheidung zwischen infiltrierendem Neoplasma (Gliom) und normalem Gewebe des Gehirns. Z. Immun -Forsch. 80, 85 (1933).Google Scholar
  473. Reichner, H., & E. Witebsky: Die serologische Unterscheidung zwischen grauer und weißer Substanz des Nervensystems. Z. Immun -Forsch. 81, 410 (1933).Google Scholar
  474. Reif, A. E., and J. M. V. Allen: The akrothymic antigen and its distribution in leukemias and nervous tissues. J. exp. Med. 120, 413 (1964).PubMedGoogle Scholar
  475. Reif, A. E., and J. M. V. Allen: Mouse nervous tissue iso-antigens. Nature (Lond.) 209, 523 (1966).Google Scholar
  476. Reiss, M., J. J. Pearse, R. H. Davis, J. C. Hillman, and M. B. Sideman: Inhibition of the biological action of gonadotrophin, thyrotrophin and corticotrophin by small amounts of serum and cerebro-spinal fluid. J. Endocr. 29, 83 (1964).Google Scholar
  477. Rendel, J., O. Aalund, R. A. Freedland, and F. Moller: The relationship between the alkaline phosphatase polymorphism and blood group 0 in sheep. Genetics 50, 973 (1964).PubMedGoogle Scholar
  478. Reusser, F.: Electrophoresis and immunology of purified bovine growth hormone. Arch. Biochem. 106, 410 (1964).Google Scholar
  479. Reynolds, M. D., and G. H. Friedell: Further observations on tumor extracts causing hemolysis in vitro. Proc. Soc. exp. Biol. (N.Y.) 114, 798 (1963).Google Scholar
  480. Ricken, D.: Myasthenia gravis und humorale Antikörper gegen menschliche Skelettmuskelproteine. Dtsch. med. Wschr. 31, 1717 (1965a).Google Scholar
  481. Ricken, D.: Humorale Antikörper gegen Humanskelettmuskelmyosinfraktionen bei Myasthenia gravis pseudoparalytica. Klin. Wschr. 43, 954 (1965b).PubMedGoogle Scholar
  482. Ricken, D. & K. O. Vorlander: Transplantationsimmunität, Immuntoleranz und Runt-disease. Dtsch. med. Wschr. 88, 2393 (1963).PubMedGoogle Scholar
  483. Ridley, A.: Localization of gamma-globulin in experimental encephalomyelitis by the fluorescent antibody technique. Z. Immun - u. Allerg.-Forsch. 125, 173 (1963).Google Scholar
  484. Rieder, H. P.: Niedermolekulare stickstoffhaltige Substanzen in Seren und Zell-Hämolysaten von MultipleSklerose-Kranken und Normalkontrollen. Psychiat. et Neurol. (Basel) 149, 210 (1965).Google Scholar
  485. Rieder, H. P., J. Ross, G. Ritzel & R. Wüthrich: Über den Nachweis von Autoantikörpern bei multipler Sklerose. Med. exp. (Basel) 11, 128 (1963).Google Scholar
  486. Ritzel, G., R. Wüthrich & H. P. Rieder: Zur Frage der Antikörper gegen Nervengewebe in Serum und Liquor von Multiple-Sklerose-Kranken. Schweiz. med. Wschr. 93, 1336 (1963).PubMedGoogle Scholar
  487. Robbins, F. C.: Evidence for and against the immunologic nature of experimental “allergic” and post-infectious encephalomyelitis. In: Allergic encephalomyelitis, p. 467–517. Springfield (Ill.): Ch. C. Thomas 1959.Google Scholar
  488. Robertis, E. de, H. M. Gerschenfeld, and F. Wald: Cellular mechanism of myelination in the central nervous system. J. biophys. biochem. Cytol. 4, 651 (1962).Google Scholar
  489. Robertson, D. M., R. Bright, and C. E. Lumsden: Dialysable peptide as the causative factor in experimental “allergic encephalomyelitis.” Nature (Lond.) 196, 1005 (1962).Google Scholar
  490. Roboz, E., and N. Henderson: Preparation and properties of water-soluble proteins from bovine cord with “allergic” encephalomyelitic activity. In: “Allergic” encephalomyelitis, p. 281. Springfield (Ill.): Ch. C. Thomas 1959.Google Scholar
  491. Roboz-Einstein, E.. D. M. Robertson, J. M. Dicaprio, and W. Moore: The isolation from bovine spinal cord of a homogenous protein with encephalitogenic activity. J. Neurochem. 9, 353 (1962).Google Scholar
  492. Roger, F., A. Roger: Etudes sur le pouvoir pathogene experimental du virus de la choriomeningite lymphocytaire. IV. Niveau de mortalite des souris après inoculation sous-cutanee plantaire. V. Distribution de la mortalite des souris au cours des reactions locales. Ann. Inst. Pasteur 105, 476 (1963).Google Scholar
  493. Roizin, L., and L. C. Kolb: Considerations on the neuropathologie pleomorphism and histogenesis of the lesions of experimental “allergic” encephalomyelitis in non-human species. In: “Allergic” encephalomyelitis. Springfield, Ill.: Ch. C. Thomas Publ. 1959.Google Scholar
  494. Rose, A. S.: Demyelinating disease: clinical features. In: Mechanisms of demyelination, p. 199. New York: McGraw-Hill Book Co. 1963.Google Scholar
  495. Rosenau, W., and H. D. Moon: Lysis of homologous cells by sensitised lymphocytes in tissue culture. J. nat. Cancer Inst. 27, 471 (1961).PubMedGoogle Scholar
  496. Ross, C. A. C., J. A. R. Lenman, and C. Rutter: Infective agents and multiple sclerosis. Brit. med. J.1965 I, 226.Google Scholar
  497. Ross, J.: Über Autosensibilisierungsvorgänge bei entzündlichen Erkrankungen des Nervensystems. Klin. Wschr. 42, 514 (1964).PubMedGoogle Scholar
  498. Ross, J.: Immunologische Charakterisierung von Gewebsantigenen des menschlichen Zentralnervensystems. Klin. Wschr. 42, 510 (1964).PubMedGoogle Scholar
  499. Ross, J., K. Schumacher & E. Mangete: Nachweis und Identifizierung eines Faktors von Immunglobulin-M-Natur und Antikörper-Eigenschaft im Serum von Kranken mit Multipler Sklerose. Klin. Wschr. 43, 1324 (1965).PubMedGoogle Scholar
  500. Rossiter, R. J.: Chemical constituents of brain and nerve. In: Neurochemistry, p. 10. Springfield, (Ill.): Ch. C. Thomas 1962.Google Scholar
  501. Rowe, W. P., P. H. Black, and R. H. Levey: Protective effect of neonatal thymectomy on mouse LCM infection. Proc. Soc. exp. Biol. (N.Y.) 114, 248 (1963).Google Scholar
  502. Rowlands Jr., D. T., W. E. C. Wilson, and Ch. H. Kirkpatric: Immunologic studies in human organ transplantation. II. The histology of passively transferred delayed hypersensitivity. J. Allergy 55, 242 (1964).Google Scholar
  503. Rowson, K. E. K.: The action of tetanus toxin in frogs. J. gen. Microbiol. 25, 315 (1961).PubMedGoogle Scholar
  504. Rubin, A. L., and K. H. Stenzel: In vitro synthesis of brain protein. Proc. nat. Acad. Sci. (Wash.) 53, 963 (1965).Google Scholar
  505. Rubinstein, L., and K. Ahrén: Growth hormone secretion in hypophysectomized rats with multiple pituitary transplants. J. Endocr. 32, 99 (1965).PubMedGoogle Scholar
  506. Rudy, H.: Über die chemische Natur des Hirnantigens. II. Mitteilung. Weiteres über die Reindarstellung des Haptens. Biochem. Z. 267, 77 (1933).Google Scholar
  507. Rudy, H.: Über Immunisierungen mit dem gereinigten organspezifischen Hapten des Gehirns. II. Mitteilung. Klin. Wschr. 13, 4 (1934).Google Scholar
  508. Ruhenstroth-Bauer, G., G. F. Fuhrmann, W. Kibler, F. Rueff U. K. Munk: Zur Bedeutung der Neura- minsäuren in der Zellmembran für das Wachstum maligner Zellen. Z. Krebsforsch. 65, 37 (1962).Google Scholar
  509. Ryan, J. W., J. D. Brown, and J. Dtrell: Antibodies affecting metabolism of chicken erythrocytes: Examination of schizophrenic and other subjects. Rep. Inst. Sci. Lab. 151, 1408 (1966).Google Scholar
  510. Sabatini, M. T., A. Pellegrino de Iraldi, and E. de Robertis: Early effects of antiserum against the nerve growth factor on fine structure of sympathetic neurons. Exp. Neurol. 12, 370 (1965).Google Scholar
  511. Salminen, A.: Difference in the agglutinability of rooster and hen erythrocytes by the thick-borne encephalitis virus. Ann. Med. exp. Fenn. 37, 400 (1959).PubMedGoogle Scholar
  512. Salminen, A.: Adsorption onto and elution from erythrocytes of the tick-borne encephalitis virus. Ann. Med. exp. Fenn. 38, 267 (1960a).PubMedGoogle Scholar
  513. Salminen, A.: Removal of tick-borne encephalitis virus receptors from erythrocytes by extraction with lipid solvents. Ann. Med. exp. Fenn. 38, 281 (1960b).PubMedGoogle Scholar
  514. Salminen, A., O.-V. Rehkonen, and O. Rennonen: Nature of lipid inhibitors of tick-borne encephalitis virus hem-agglutination. I. Inhibitory lipids of human serum. Ann. Med. exp. Fenn. 38, 447 (1960a).Google Scholar
  515. Salminen, A., O.-V. Rehkonen, and O. Rennonen: Nature of lipid inhibitors of tick-borne encephalitis virus hemagglutination. II. Inhibitory activity of authentic lipids and their mixtures. Ann. Med. exp. Fenn. 38, 456 (1960b).PubMedGoogle Scholar
  516. Salmon, Ch.: Sur le mécanisme des modification des groupes sanguins au cours des leucémies aigues tumorales de génétiques. Ann. Génét. 7, 3 (1964).PubMedGoogle Scholar
  517. Saragea, M., T. Negru, N. Rotaru, and A. Vladutiu: Agglutinating anti-brain antibodies in dogs with experimental allergic encephalomyelitis. Experientia (Basel) 21, 196 (1965).Google Scholar
  518. Saragea, M., A. Vladutiu, N. Rotaru, and T. Negru: The problem of circulating antibrain antibodies in experimental allergic encephalomyelitis. Acta allerg. (Kbh.) 21, 139 (1966).Google Scholar
  519. Schalekamp, M. A. H. D., and M. P. A. Kuyken: Comparative studies of human-brain and blood proteins: an electrophoretic and serologic investigation. Protid. Biol. Fluids X, 243 (1961).Google Scholar
  520. Schatz, A., and L. M. Adelson: Experimental in vitrio demyelination. Neurology (Minneap.) 8, 113 (1958).Google Scholar
  521. Schedifka, R.: Zum Krankheitsbild der postvakzinalen Encephalomyelitis nach Lyssaschutzimpfung. Arch. Hyg. (Berl.) 148, 229 (1964).Google Scholar
  522. Scheibe, E., & N. Gibb: Über das Vorkommen von blutgruppenaktiven Substanzen in der harten Hirnhaut. Acta biol. med. germ. 7, 87 (1961).PubMedGoogle Scholar
  523. Scheid, W.: Lehrbuch der Neurologie, 2. Aufl. Stuttgart: Georg Thieme 1966.Google Scholar
  524. Scheiffarth, F: Immunpathologische Probleme bei der Organtransplantation. Dtsch. med. Wschr. 86, 1329 (1961).Google Scholar
  525. Scheiffarth, F: Die Transplantationsimmunität. Med. Welt 36, 1874 (1962).Google Scholar
  526. Scheinberg, L. C., F. L. Edelman, and W. A. Levy: Is the brain “an immunologically privileged site” ? Arch. Neurol. (Chic.) 11, 248 (1964).Google Scholar
  527. Scheinberg, L. C., W. A. Levy, and F. Edelman: Is the brain an “immunologically privileged site ?” 2. Studies in induced host resistance to transplantable mouse glioma following irradiation of prior implants. Arch. Neurol. (Chic.) 13, 283 (1965).Google Scholar
  528. Scheinberg, L. C., K. Suzuki, L. M. Davidoff, and R. L. Beilin: Immunization against intracerebral transplantation of glioma in mice. Nature (Lond.) 193, 1194–1195 (1962a).Google Scholar
  529. Scheinberg, L. C., M. C. Levine, K. SuzuxT, and R. D. Terry: Induced host resistance to a transplantable mouse glioma. Cancer Res. 22, 67–72 (1962b).PubMedGoogle Scholar
  530. Scheinberg, L. C. et al.: Studies in immunization against a transplantable cerebral mouse glioma. J. Neurosurg. 20, 312–316 (1963).PubMedGoogle Scholar
  531. Schi-Gie, H., and V. V. Pogodina: Use of fluorescent antibody technique in studies on far-east tick-borne encephalitis in mice, hamsters and pigs. Acta virol. 8, No 1 (1964).Google Scholar
  532. Schmidt, N. J., J. Dennis, M. N. Hoffman, and E. H. Lennette: Inhibitors of echovirus and reovirus hemagglutination. II. Serum and phospholipid inhibitors. J. Immunol. 93, No 3 (1964).Google Scholar
  533. Schmitt, F. O.: The ultrastructure of the nerve myelin sheath. Res. Publ. Ass. nerv. ment. Dis. 28, 247 (1950).Google Scholar
  534. Schneider, H. A.: Genetic and nutritional aspects of experimental “allergic” encephalomyelitis. In: “Allergic” encephalomyelitis, p. 130. Springfield (Ill.): Ch. C. Thomas 1959.Google Scholar
  535. Schneider, L. G.: Erfahrungen mit fluoreszenzmarkierten Antikörpern bei der routinemäßigen Laboratoriumsdiagnose der Tollwut. I. Mitteilung: Die fluoreszierende Antikörpertechnik. Zbl. Vet.-Med., Reihe B 11, 207 (1964).Google Scholar
  536. Schrader, A.: Die experimentellen Grundlagen der Encephalomyelitis. In: Immunpathologie in Klinik und Forschung. Stuttgart: Georg Thieme 1961a.Google Scholar
  537. Schrader, A.: Klinische Immunbiologie der Polyneuritis und der Entmarkungskrankheiten. In: Immunpathologie in Klinik und Forschung. Stuttgart: Georg Thieme 1961b.Google Scholar
  538. Schwab, E.: Über ein neues in der Protagonfraktion des Hirns enthaltenes Hapten. Z. Immun.-Forsch. 87, 426 (1936).Google Scholar
  539. Schwartz, R. S.: Alteration of immunity by antimetabolites. Concept. Adv. Immunol. Oncol., Hoeber Med. Divis., Harper & Row, 1963, 137.Google Scholar
  540. Schwarz, H. P., I. Kostyk, A. Marmelejo, and P. Panageotopoulos: Brain sphingolipids in experimental “allergic” encephalomyelitis. Proc. Soc. exp. Biol. (N.Y.) 119, 42 (1965).Google Scholar
  541. Schwarz-Speck, M., E. Maeder: Immunologische Untersuchungen mit natürlichem und synthetischem ACTH bei ACTH-Allergikern. Int. Arch. Allergy Suppl. 24, 29 (1964).Google Scholar
  542. Seaman, G. V. F., and G. Uhlenbruck: The surface structure of erythrocytes from some animal sources. Arch. Biochem. Biophys. 100, 493 (1963).Google Scholar
  543. Seitelberger, F.: Veränderungen des Zentralnervensystems durch Impfkomplikationen. Wien. med. Wschr. 114, 279 (1964).Google Scholar
  544. Selariu, C.: The comparative study of soluble antigens in mitochondria and cell-sap of rat brain. Rev. roum. Biochim. 2, 79 (1965).Google Scholar
  545. Shaffer, M. F.: Sero-protection against intracerebral Salmonella typhosa infection in chicks. Proc. Soc. exp. Biol. (N.Y.) 118, 71 (1965).Google Scholar
  546. Shaw, C., E. C. Alvord, and M. W. Kies: Straight chain hydrocarbons as substitutes for the oil in Freund’s adjuvans in the production of experimental “allergic” encephalomyelitis in the guinea pig. J. Immunol. 92, 24 (1964a).PubMedGoogle Scholar
  547. Shaw, C., E. C. Alvord, W. J. Faulberg, and M. W. Kies: Substitutes for the mycobacteria in Freund’s adjuvans in the production of experimental “allergic” encephalomyelitis in the guinea pig. J. Immunol. 92, 28 (1964b).PubMedGoogle Scholar
  548. Sherrington, C.: Integratice action of the nervous system. Cambridge: University Press 1937.Google Scholar
  549. Shiraki, H., and S. Otani: Clinical and pathological features of rabies post-vaccinal encephalomyelitis in man. In: “Allergic” encephalomyelitis. Springfield, (Ill.): Ch. C. Thomas 1959.Google Scholar
  550. Shulman, S., F. Milgrom, and E. Witebsky: Immunological studies on adrenal glands. IV. Chemical studies on the bovine thermostable adrenal-specific antigen. Immunology 7, 605 (1964).PubMedGoogle Scholar
  551. Sibley, W. A., and L. Wurz: Immunoassay of cerebrospinal fluid gamma-globulin. Arch. Neurol. 9, 386 (1963).Google Scholar
  552. Silverstein, A., M. M. Feuer, and L. E. Siltzbach: Neurologic sarcoidosis. Arch. Neurol. (Chic.) 12, 1 (1964).Google Scholar
  553. Silverstone, B., and D. R. Cooper: Astrocytomas and ABO blood groups. J. Neurosurg. 18 602 (1961).Google Scholar
  554. Simpson, C. A., A. Vejjajiva, E. A. Caspary, and H. Miller: ABO blood-groups in multiple sclerosis. Lancet 1965 I, 1366.Google Scholar
  555. Singer, S. J.: Preparation of an electron-dense antibody conjugate. Nature (Lond.) 183, 1523 (1959).Google Scholar
  556. Sinkovics, J. G.: New concepts in immunology. Exp. Med. Surg. 21, 251 (1963).Google Scholar
  557. Sjögren, H. O.: Studies on specific transplantation resistance to polyoma-virus-induced tumors. III. Transplantation resistance to genetically compatible polyoma tumors induced by polyoma tumor homografts. J. nat. Cancer Inst. 32, No 3 (1964).Google Scholar
  558. Sjögren, H. O.: Studies on specific transplantation resistance to polyoma-virus-induced tumors. IV. Stability of the polyoma cell antigen. J. nat. Cancer Inst. 32, No 3 (1964).Google Scholar
  559. Sjöstrand, F. S.: The structure and formation of the myelin sheath. In: Mechanism of demyelination (ed. A. S. Rose and C. M. Pearson). New York: McGrawe-Hill Bock Co. 1963.Google Scholar
  560. Sköldenberg, B.: Aseptic meningitis and meningoencephalitis in cold-agglutinin-positive infections. Brit. med. J. 1965 I, 100.Google Scholar
  561. Smith, M. E.: Glucose metabolism of central nervous tissues in rats with experimental allergic encephalomyelitis. Nature (Lond.) 209, 1031 (1966).Google Scholar
  562. Smith, M. E.: Lipid biosynthesis in the central nervous system in experimental allergic encephalomyelitis. J. Neurochem. 11, 29 (1964).PubMedGoogle Scholar
  563. Smith, W. G.: Release of ganglioside from guinea-pig lung tissue during anaphylaxis. Nature (Lond.) 209, 1251 (1966).Google Scholar
  564. Somers, J. E.: Myelin antibodies in experimental allergic encephalomyelitis. Neurology (Minneap.) 14, 232 (1964).Google Scholar
  565. Somers, J. E., J. N. Kanfer, and R. O. Brady: Sphingolipid antibodies. II. Specificity of antibody in patients with demyelinating diseases. Proc. Soc. exp. Biol. (N.Y.) 114, 350 (1963).Google Scholar
  566. Somers, J. E., J. N. Kanfer, R. O. Brady, and J. M. Boone: Immunchemical studies with gangliosides. II. Investigations of the structure of gangliosides by the hapten-inhibition technique. Biochem. 3, 251 (1964).Google Scholar
  567. Southam, C. M.: Relationships of immunology to cancer: a review. Cancer Res. 20, No 3 (1960).Google Scholar
  568. Southam, C. M.: Host defense mechanisms and human cancer. Ann. Inst. Pasteur 107, 585 (1964).Google Scholar
  569. Speiser, P.: Krankheiten and Blutgruppen. Krebsarzt 4, 208 (1958).Google Scholar
  570. Spencer, A. T., and W. T. Smith: Behavior of intracerebral autografts of mouse tail skin pre-treated with a single application of 20-methylcholanthrene. Nature (Lond.) 207, 649 (1965).Google Scholar
  571. Sperry, W. M.: The biochemistry of the brain during early development. In: K. A. C. Elliot, J. H. Page & J. H. Quastel, Neurochemistry, pp. 55. Springfield (Ill.): Ch. C. Thomas 1962.Google Scholar
  572. Stahl, W. L., J. C. Smith, L. M. Napolitano, and R. E. Basford: Isolation of bovine mitochondria. J. Cell Biol. 19, 293 (1963).PubMedGoogle Scholar
  573. Stam, F. C.: Neuropathological and chemical aspects of diffuse demyelinating diseases. Psychiat. Neurol. Neurochir. (Amst.) 67, 332 (1964).Google Scholar
  574. Stary, Z., A. Wardi, and D. Turner: Galacturonic acid in hydrolysates of defatted human brain. Biochim. biophys. Acta (Amst) 83, 242 (1964).Google Scholar
  575. Stary, Z., A. Wardi, D. Turner, and W. S. Allen: Arabinose as a mucopolysaccharide component in human and animal brain tissue. Arch. Biochem. 110, 388 (1965).Google Scholar
  576. Stauffer, R. E., and B. H. Waksman: Dermal and serological reactions to nervous tissue antigens in multiple sclerosis. Ann. N.Y. Acad. Sci. 58, 570 (1954).Google Scholar
  577. Stein, A. A., E. Opalka, and F. Peck: Fatty acid analysis by gas chromatography. Arch. Neurol. Psychiat. (Chic.) 8, 50 (1963a).Google Scholar
  578. Stein, A. A., E. Opalka, and I. Rosenblum: Fatty acid analysis of two experimental transmissible glial tumors by gas-liquid chromatography. Cancer Res. 25, 201 (1965).PubMedGoogle Scholar
  579. Stein, A. A., E. Opalka, and I. Rosenblum: Hepatic lipids in tumor-bearing (glioma) mice. Cancer Res. 25, 957 (1965).PubMedGoogle Scholar
  580. Stein, A. A., E. Opalka, and A. O. Shilp: Fatty acid analysis of meningiomas by gas phase chromatography. J. Neurosurg. 20, 435 (1963b).PubMedGoogle Scholar
  581. Stöss, B.: Papierchromatographische Darstellung von Antigen-Antikörper-Reaktionen. Zbl. Bakt., I. Abt. Orig. 179, 72 (1960).Google Scholar
  582. Svenneeholm, L.: On sialic acid in brain tissues. Acta chem. scand. 10, 694 (1956).Google Scholar
  583. Svenneeholm, L.: The distribution of lipids in the human nervous system. I. Analytical procedure. Lipids of foetal and newborn brain. J. Neurochem. 11, No 12 (1964a).Google Scholar
  584. Svenneeholm, L.: The gangliosides. J. Lipid Res. 5, 145 (1964b).Google Scholar
  585. Svennilson, E., S. J. Dencker, and B. Swaxx: Immunoelectrophoretic studies of cerebrospinal fluid. Neurology (Minneap.) 11, No 11 (1961).Google Scholar
  586. Swaen, G. J. V.: A study of the antigenicity of a human cell line propagated in a heterologous medium. Experientia (Basel) 19, No 19, 628 (1963).Google Scholar
  587. Swahn, B., R. Brönnestam, and S. J. Dencker: On the origin of the lipoproteins in the cerebrospinal fluid. Neurology (Minneap.) 11, No 5 (1961).Google Scholar
  588. Széky, J., A. HässiG & A. Prader: Über Antikörper gegen menschliches Wachstumshormon vom Typus Raben bei Patienten mit Zwergwuchs. Helv. paediat. Acta 17, 411 (1962).Google Scholar
  589. Taketomi, T., and T. Yamakawa: Immunchemical studies of lipids. J. Biochem. (Tokyo) 54, 444 (1963).Google Scholar
  590. Taketomi, T., and T. Yamakawa: Further confirmation on the structure of brain cerebroside sulfuric ester. J. Biochem. (Tokyo) 55, 87 (1964).Google Scholar
  591. Taketomi, T., and T. Yamakawa: Preparation and immunological properties of synthetic sphingosin protein complex. Jap. J. exp. Med. 35, No 4 (1965).Google Scholar
  592. Taltaferro, W. H., L. G. Tallaferro, and B. N. Jaroslow: Radiation and immune mechanisms. New York: Academic Press 1964.Google Scholar
  593. Tarrant, C. J., E. H. Fife, and L. H. Muschel: Complement levels in experimental allergic encephalomyelitis. Nature (Lond.) 202. 819 (1964).Google Scholar
  594. Tashjian, A. H., L. Levine, and P. L. Munson: Immunoassay of parathyroid hormone by quantitative complement fixation. Endocrinology 74, 244 (1964b).PubMedGoogle Scholar
  595. Tashjian, A. H., D. A. Ontjes, and P. L. Munson: Alkylation and oxidation of methionine in bovine parathyroid hormone: effects on hormonal acticity and antigenicity. Rep. Biochem. 3, 1175 (1964a).Google Scholar
  596. Tateno, I.: Incubation period and the initial symptoms of tetanus: A clinical assessment of the problem of the passage of tetanus toxin to the central nervous system. Jap. J. exp. Med. 33, 149 (1963).PubMedGoogle Scholar
  597. Taubert, M., & O. Weller: Chromatographische Gonadotropingewinnung. Klin. Wschr. 34, 84–86 (1956).Google Scholar
  598. Tee, D. E. H., M. Wang, and J. Watkins: Antigenic properties of human tumours. Nature (Lond.) 204, 897 (1964).Google Scholar
  599. Teichmann, B., & R. Vogt: Unspezifische Lipoproteid-Präzipitationen im Agar-Gel. Acta biol. med. germ. 12, 591 (1964).PubMedGoogle Scholar
  600. Teichmann, B., G. Wittig & U. Schneeweiss: Versuche zum Nachweis krebsspezifischer Autoantikörper beim Menschen. Acta biol. med. germ. 10, 618 (1963).PubMedGoogle Scholar
  601. Thompson, G. E.: A brief report of a method for partial purification of EAE antigen. Cornell Vet. 55, No 1 (1965).Google Scholar
  602. Thompson, R. H. S.: Myelinolytic mechanism. Proc. roy. Soc. Med. 54, 30 (1961).PubMedGoogle Scholar
  603. Thompson, R. H. S.: A biochemical approach to the problem of multiple sclerosis. Proc. roy. Soc. Med. 59, 269 (1966).PubMedGoogle Scholar
  604. Tippett, P., R. Sanger, R. R. Race, J. Swanson, and S. Busch: An agglutinin associated with the P and the ABO blood group systems. Vox Sang (Basel) 10, 269 (1965).Google Scholar
  605. Tönder, O., F. Milgrom, and E. Witebsky: Mixed agglutination with tissue sections. J. exp. Med. 119, 265 (1964).Google Scholar
  606. Tolle, A.: Die Blutgruppen des Rindes. Hannover: M. & H. Schaper 1960.Google Scholar
  607. Touber, J. L., and D. Maingay: Heterogeneity of human growth hormone. Lancet 1963 I, 1403–1405.Google Scholar
  608. Uhlenbruck, G.: Zur Definition der Panhämagglutination unter besonderer Berücksichtigung des ThomsenFriedenreichschen Phänomens. Zbl. Bakt., 179, 155 (1961).Google Scholar
  609. Uhlenbruck, G. & M. Krupe: Weitere serologische Eigenschaften von Mucoiden aus Rindererythrozytenstroma: Spezifische Reaktionsfähigkeit mit Phytagglutininen aus Solanum tuberosum und Ricinus communis sowie mit Anti-Pneumokokken-Typ-XIV-Pferdeserum. Z. Immun.-Forsch. 125, 285 (1963a).Google Scholar
  610. Uhlenbruck, G. & M. Krupe: A mucoid isolated from bovine red cells exhibiting strong pneumococcus type XIV cross-reactivity. Nature (Lond.) 199, 1289 (1963b).Google Scholar
  611. Uhlenbruck, G. & M. Krupe: Das Studium der Zelloberfläche mit Hilfe von Enzymen. Mitteil. Max-Planck-Gesellsch. 4, 227 (1965).Google Scholar
  612. Unterharnscheidt, F., & O. Bonin: Zur Neurovirulenzprüfung von Poliomyelitis-Lebendimpfstoffen. II. Pathomorphologie der Affenpoliomyelitis durch attenuierte Polioviren nach intralumbaler Injektion unter besonderer Berücksichtigung der Unterschiede zwischen den Virustypen. Arch. Psychiat. Nervenkr. 206, 454 (1965).Google Scholar
  613. Ursing, B., S. J. Dencker, and B. Swahn: Protein pattern of cerebrospinal fluid in meningitis and meningoencephalitis. Acta med. scand. 171, fasc. 6 (1962).Google Scholar
  614. Utiger, R. D.: Wachstumshormon im menschlichen Serum. J. clin. Endocr. 24, 60 (1964).PubMedGoogle Scholar
  615. Utiger, R. D., W. D. Odell, and P. G. Condliffe: Immunologic studies of purified human and bovine thyrotropin. Endocrinology 73, 359 (1963).PubMedGoogle Scholar
  616. Vest, M., J. Girard, and M. Y. van Caillie: The role of nonspecific inhibition in the immuno-assay for growth hormone. Nature (Lond.) 192, 1051 (1961).Google Scholar
  617. Vilcek, J., J. Tomisova, F. Sokol, and L. Hana: Concentration and partial purification of interferon from mouse brains. Acta virol. 8, 76 (1964).PubMedGoogle Scholar
  618. Vogt, P. K.: The cell surface in tumor virus infection. Cancer. Res. 23, 1519 (1963).Google Scholar
  619. Voisin, G. A.: Greffes tumorales et facilitation immunologique (“Immunological Enhancement”). Kritischer Überblick. Rev. franç. Étud. clin. biol. 8, 927 (1963).PubMedGoogle Scholar
  620. Voisin, G. A.: Hypersensibilité cellulaire et anticorps humoraux dans les immunités anti-tissue. (Autoimmunité et immunité de transplantation.) Rev. franç. Etud. clin. biol. 9, 326 (1964).PubMedGoogle Scholar
  621. Volk, B. W.: Tay-Sachs-disease. New York: Grune & Stratton 1964.Google Scholar
  622. Volkert, M., & J. H. Larsen: Studies on immunological tolerance to LCM virus. 3. Duration and maximal effect of adoptive immunization of virus carriers. Acta path. microbiol. scand. 60, 577 (1964a).PubMedGoogle Scholar
  623. Volkert, M., & J. H. Larsen: Studies on immunological tolerance to LCM virus. 5. The induction of tolerance to the virus. Acta path. microbiol. scand. 63, 161 (1965a).PubMedGoogle Scholar
  624. Volkert, M., & J. H. Larsen: Studies on immunological tolerance to LCM virus 6 Immunity conferred on tolerant mice by immune serum and by grafts of homologous lymphoid cells. Acta path. microbiol. scand. 63, 172 (1965b).PubMedGoogle Scholar
  625. Volkert, M., J. H. Larsen, and C. J. Pfau: Studies on immunological tolerance to LCM virus. 4. The question of immunity in adoptively immunized virus carriers. Acta path. microbiol. scand. 61, 268 (1964b).PubMedGoogle Scholar
  626. Vorherr, H.: Der Nachweis von Chorion-und hypophysären Gonadotropinen mittels abgestufter Antigen-Antikörperreaktion (Pregnosticontest). Acta med. Nordmark 5, 492 (1964).Google Scholar
  627. Vulchanov, V. H., and Y. Hadjieva: On possibilities of auto-immunization in mental patients. C. R. Acad. bulg. Sci. 17, 311 (1964).PubMedGoogle Scholar
  628. Wadja, I. J., H. Waelsch, and J. M. Lee: Transglutaminase and experimental allergic encephalomyelitis. Life Sci. 4, 1853 (1965).Google Scholar
  629. Waksman, B. H.: Evidence favoring delayed sensitization as the mechanism underlying experimental allergic encephalomyelitis. In: “Allergic” encephalomyelitis, p. 419. Springfield, Ill.: Ch. C. Thomas 1959a.Google Scholar
  630. Waksman, B. H.: Activity of proteolipid-containing fractions of nervous tissue in producing experimental “allergic” encephalomyelitis. In: “Allergic” encephalomyelitis. Springfield, Ill.: Ch. C. Thomas 1959b.Google Scholar
  631. Waksman, B. H.: Experimentelle immunologische Erkrankungen des peripheren Nervensystems. In: Immunpathologie in Klinik und Forschung. Stuttgart: Georg Thieme 1961.Google Scholar
  632. Waksman, B. H.: Tissue damage in the “delayed” (cellular) type of hypersensitivity. In: Mechanism of cell and tissue damage produced by immune reactions. Basel: Benno Schwabe & Co. 1962.Google Scholar
  633. Waksman, B. H.: Les base cellulaires de la réponse immunitaire. Ann. Inst. Pasteur 105, 465 (1963).Google Scholar
  634. Waksman, B. H.: Experimental immunologic disease of the peripheral nervous system. In: Mechanisms of demyelination, p. 170–198. New York: McGraw-Hill Book Co. 1963.Google Scholar
  635. Waksman, B. H.: The local reaction of cellular hypersensitivity. Ann. N.Y. Acad. Sci. 116, 1045 (1964).PubMedGoogle Scholar
  636. Waksman, B. H.: Animal investigations in autosensitization: Nervous system. Ann. N.Y. Acad. Sci. 124, 299 (1965).PubMedGoogle Scholar
  637. S. Arbouys, and B. G. Arnason: The use of specific “lymphocyte” antisera to inhibit hypersensitive reactions of the “delayed” type. J. exp. Med. 114, 997 (1961).PubMedGoogle Scholar
  638. Webster, E. A., and D. R. Laurence: The effect of antitoxin on fixed and free toxin in experimental tetanus. J. Path. Bact. 86, 413 (1963).PubMedGoogle Scholar
  639. Webster, G. R.: Clearing action of lysolecithin on brain homogenates. Nature (Lond.) 180, 660 (1957).Google Scholar
  640. Weiner, L. P., P. N. Anderson, and J. C. Allen: Cerebral plasmacytoma with myeloma protein in the CSF. Neurology 16, 615 (1966).PubMedGoogle Scholar
  641. Weil, A., and E. Liebert: Antigenic properties of brain tumors. J. Immunol. 30, 291 (1936).Google Scholar
  642. Weil, A., and E. Liebert: Antigenic properties of brain tumors. J. Immunol. 92, 82 (1964).Google Scholar
  643. Weiser, P.: Zur immunologischen Bestimmung von hypophysären Gonadotropinen. Klin. Wschr. 42, 292 (1964).Google Scholar
  644. Wenzel, B. M., and B. Nagle: The effects of immunological sympathectomy on behavior in mice. Exp. Neurol. 12, 399 (1965).Google Scholar
  645. West, M., R. M. Poske, A. B. Biack, C. G. Pilz, and H. J. Zimmerman: Enzyme activity in synovial fluid. J. Lab. clin. Med. 62, 175 (1963).PubMedGoogle Scholar
  646. Westhues, M.: Untersuchungen an marklosen Nervenfasern über den Wirkungsort von Botulismus-und Tetanustoxin. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 246, 309 (1964).Google Scholar
  647. White, R. G., P. Jolles, D. Samour, and E. Lederer: Correlation of adjuvant activity and chemical structure of wax D fractions of mycobacteria. Immunology 7, 158 (1964).PubMedGoogle Scholar
  648. White, R. J., M. S. Albin, G. E. Locke, and E. Davidson: Brain transplantation: prolonged survival of brain after carotid-jugular interposition. Science 150, 779 (1965).PubMedGoogle Scholar
  649. Whitehead, R.: The hypothalamic lesion of the multiple endocrine adenoma syndrome. Acta neuropath. (Berl.) 4, 191 (1964).Google Scholar
  650. Whittaker, V. P., I. A. Michaelson, and R. J. A. Kirland: The separation of synaptic vesicles from nerve-ending particles (“synaptosomes”). Biochem. J. 90, 293 (1964).PubMedGoogle Scholar
  651. Wiegandt, H., & G. Basciiang: Die Gewinnung des Zuckeranteiles der Glykosphingolipide durch Ozonolyse and Fragmentierung. Z. Naturforsch. 20b, 164 (1965).Google Scholar
  652. Wiener, A. S.: Blood groups and diseases. Lancet 1962 I, 813.Google Scholar
  653. Wight, P. A. L., and W. G. Siller: Further studies of experimental allergic encephalomyelitis in the fowl. II. The influence of dose variations on the histological lesions. Immunology 6, 513 (1963).PubMedGoogle Scholar
  654. Wight, P. A. L., and W. G. Siller: Further studies of experimental allergic encephalomyelitis in the fowl. IV. The suppression of the experimental lesions by a naturally-occurring neuritis. Res. Vet. Sci. 6, 324 (1965).Google Scholar
  655. Wilkinson, P. C.: Serological findings in carcinomatous neuromyopathy. Lancet 1964 I, 1301.Google Scholar
  656. Wilkinson, P. C., and J. Zeromski: Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy. Reprinted from: Brain 88, 529 (1965).Google Scholar
  657. Williams, C. H., and B. Rothfeld: In vivo incorporation of iodinated anti-rat brain globulin and normal globulin into rat organs. Proc. Soc. exp. Biol. (N.Y.) 113, 613 (1963).Google Scholar
  658. Wilson, W. H.: Pathogenesis of neurological manifestations of allergic disease. Ann. Allergy 24, 371 (1966).PubMedGoogle Scholar
  659. Winick, M., and R. E. Greenberg: Appearance and localization of a nerve growth-promoting protein during development. Pediatrics 35, 221 (1965).PubMedGoogle Scholar
  660. Witebsky, E.: The status of organ specificity. In: “Allergic” encephalomyelitis. Springfield, Ill.: Ch. C. Thomas 1959.Google Scholar
  661. Witebsky, E. & J. Steinfeld: Untersuchungen über spezifische Antigenfunktionen von Organen. Z. Immun.-Forsch. 58, 271 (1928).Google Scholar
  662. Wolf, A.: Discussion of the reaction of different species to injection of brain-containing vaccines. In: “Allergic” encephalomyelitis. Springfield, Ill.: Ch. C. Thomas 1959.Google Scholar
  663. Wolf, A.: Spontaneous human and experimental simian demyelinating disease. In: Mechanism of demyelination, edit. by A. S. Rose and C. M. Pearson, p. 72. New York: McGrawe Hill Co. 1963.Google Scholar
  664. Woodhour, A. F., D. P. Metzgar, T. B. Stim, A. A. Tytell, and M. R. Hilleman: New metabolizable immunologic adjuvans for human use. I. Development and animal immune response. Proc. Soc. exp. Biol. (N.Y.) 116, 516 (1964).Google Scholar
  665. Woodruff, MFA: Immunological aspects of cancer. Lancet 1964 I, 265.Google Scholar
  666. Woodruff, MFA: Serotonin receptors. VII. Activities of various pure gangliosides as the receptors. Proc. nat. Acad. Sci. (Wash.) 53, 959 (1965).Google Scholar
  667. Wrba, H., V. Kinzel & H. Rabes: Zur Wirkung von Antiserum auf Tumorzellkulturen. Naturwissenschaften 51, H. 15 (1964).Google Scholar
  668. Wright, E. A., R. S. Morgan, and G. P. Wright: The movement of toxin in the nervous system in experimental tetanus. Brit. J. exp. Path. 32, 169 (1951).PubMedGoogle Scholar
  669. Wright, R., J. A. Morton, and K. B. Taylor: Immunological studies in multiple sclerosis: Incidence of antibodies to dietary proteins and auto-antigens. Brit. med. J. 1965 I, 491.Google Scholar
  670. Wuthrich, R.: Probleme der experimentellen allergischen Encephalomyelitis. Basel u. New York: S. Karger 1964.Google Scholar
  671. Wuthrich, R., H. P. Rieder & G. Ritzel: Beeinflussung der experimentellen allergischen Encephalomyelitis durch e-Aminocapronsäure. Experientia (Basel) 19, 422 (1963).Google Scholar
  672. Yalow, R. S., S. M. Glick, J. Roth, and S. A. Berson: Radioimmunoassay of human plasma ACTH. J. clin. Endocr. 24, 1219 (1964).PubMedGoogle Scholar
  673. Yasamura, S., and K. M. Knigge: Growth and function of thyroid grafts implanted in the rat brain. Acta endocr. (Kbh.) 45, 178 (1964).Google Scholar
  674. Yates, P. O., and K. M. Pearce: Recent change in blood group distribution of astrocytomas. Lancet 1960 I, 194.Google Scholar
  675. Yokoyama, M.: Close relationship between A and I blood groups. Nature (Lond.) 206, 411 (1965).Google Scholar
  676. Yokoyama, M., and B. Plocinik: Ganglioside inhibition of blood group antibodies with special reference to blood group I. Z. Immun.-Forsch. 129, 137 (1965).Google Scholar
  677. Yokoyama, M., E. G. Trams, and R. O. Brady: Sphingolipid antibodies in sera of animals and patients with central nervous system lesions. Proc. Soc. exp. Biol. (N.Y.) 111, 350 (1962).Google Scholar
  678. Yokoyama, M., E. G. Trams, and R. O. Brady: Immunchemical studies with gangliosides. J. Immunol. 90, 372–380 (1963).Google Scholar
  679. Zu Rhein, G. M., and S.-M. Chou: Particles resembling Papova viruses in human cerebral demyelinating disease. Science 148, 1477 (1965).Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1968

Authors and Affiliations

  • G. Uhlenbruck

There are no affiliations available

Personalised recommendations